#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


1-1	0-3	The	_
1-2	4-14	cerebellum	_
1-3	15-18	and	_
1-4	19-27	learning	_
1-5	28-30	of	_
1-6	31-40	non-motor	_
1-7	41-53	associations	_
1-8	54-56	in	_
1-9	57-68	individuals	_
1-10	69-71	at	_
1-11	72-85	clinical-high	_
1-12	86-90	risk	_
1-13	91-94	for	_
1-14	95-104	psychosis	_
1-15	105-108	The	_
1-16	109-135	cerebello-thalamo-cortical	_
1-17	136-143	circuit	_
1-18	144-145	(	_
1-19	146-150	CTCC	_
1-20	151-152	)	_
1-21	153-156	has	_
1-22	157-161	been	_
1-23	162-172	implicated	_
1-24	173-175	in	_
1-25	176-189	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-26	190-191	.	_

2-1	192-199	However	_
2-2	200-201	,	_
2-3	202-206	this	_
2-4	207-211	work	_
2-5	212-215	has	_
2-6	216-220	been	_
2-7	221-228	limited	_
2-8	229-231	to	_
2-9	232-242	structural	_
2-10	243-246	and	_
2-11	247-257	functional	_
2-12	258-266	networks	_
2-13	267-268	,	_
2-14	269-271	or	_
2-15	272-280	behavior	_
2-16	281-282	,	_
2-17	283-286	and	_
2-18	287-289	to	_
2-19	290-294	date	_
2-20	295-296	,	_
2-21	297-300	has	_
2-22	301-304	not	_
2-23	305-309	been	_
2-24	310-319	evaluated	_
2-25	320-322	in	_
2-26	323-331	clinical	_
2-27	332-341	high-risk	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk
2-28	342-343	(	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk
2-29	344-347	CHR	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk
2-30	348-349	)	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk
2-31	350-355	youth	_
2-32	356-357	,	_
2-33	358-359	a	_
2-34	360-365	group	_
2-35	366-368	at	_
2-36	369-377	elevated	_
2-37	378-382	risk	_
2-38	383-386	for	_
2-39	387-396	psychosis	_
2-40	397-398	.	_

3-1	399-403	Here	_
3-2	404-405	,	_
3-3	406-408	we	_
3-4	409-413	used	_
3-5	414-416	an	_
3-6	417-427	innovative	_
3-7	428-436	learning	_
3-8	437-445	paradigm	_
3-9	446-451	known	_
3-10	452-454	to	_
3-11	455-463	activate	_
3-12	464-467	the	_
3-13	468-472	CTCC	http://maven.renci.org/NeuroBridge/neurobridge#Thing
3-14	473-474	(	_
3-15	475-480	while	_
3-16	481-489	limiting	_
3-17	490-499	potential	_
3-18	500-505	motor	_
3-19	506-515	confounds	_
3-20	516-517	)	_
3-21	518-520	to	_
3-22	521-529	evaluate	_
3-23	530-533	CHR	http://maven.renci.org/NeuroBridge/neurobridge#ChronicPain
3-24	534-537	and	_
3-25	538-545	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
3-26	546-553	control	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
3-27	554-565	individuals	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
3-28	566-572	during	_
3-29	573-583	functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
3-30	584-592	magnetic	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
3-31	593-602	resonance	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
3-32	603-610	imaging	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
3-33	611-612	(	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
3-34	613-617	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
3-35	618-619	)	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
3-36	620-621	.	_

4-1	622-624	20	_
4-2	625-628	CHR	http://maven.renci.org/NeuroBridge/neurobridge#ChronicPain
4-3	629-632	and	_
4-4	633-635	21	_
4-5	636-643	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
4-6	644-651	control	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
4-7	652-663	individuals	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
4-8	664-673	performed	_
4-9	674-675	a	_
4-10	676-688	second-order	http://maven.renci.org/NeuroBridge/neurobridge#II
4-11	689-693	rule	http://maven.renci.org/NeuroBridge/neurobridge#II
4-12	694-702	learning	http://maven.renci.org/NeuroBridge/neurobridge#II
4-13	703-707	task	http://maven.renci.org/NeuroBridge/neurobridge#II
4-14	708-713	while	http://maven.renci.org/NeuroBridge/neurobridge#II
4-15	714-724	undergoing	http://maven.renci.org/NeuroBridge/neurobridge#II
4-16	725-729	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
4-17	730-731	.	_

5-1	732-736	This	_
5-2	737-740	was	_
5-3	741-749	preceded	_
5-4	750-753	and	_
5-5	754-762	followed	_
5-6	763-765	by	_
5-7	766-769	the	_
5-8	770-778	paradigm	_
5-9	779-784	under	_
5-10	785-794	dual-task	_
5-11	795-805	conditions	_
5-12	806-807	.	_

6-1	808-810	In	_
6-2	811-819	addition	_
6-3	820-821	,	_
6-4	822-825	all	_
6-5	826-838	participants	_
6-6	839-848	underwent	_
6-7	849-859	structured	_
6-8	860-868	clinical	_
6-9	869-879	interviews	_
6-10	880-882	to	_
6-11	883-890	confirm	_
6-12	891-892	a	_
6-13	893-902	prodromal	_
6-14	903-911	syndrome	_
6-15	912-915	and	_
6-16	916-922	assess	_
6-17	923-930	symptom	_
6-18	931-939	severity	_
6-19	940-941	.	_

7-1	942-945	The	_
7-2	946-950	rate	_
7-3	951-953	of	_
7-4	954-962	learning	_
7-5	963-966	did	_
7-6	967-970	not	_
7-7	971-977	differ	_
7-8	978-985	between	_
7-9	986-992	groups	_
7-10	993-994	.	_

8-1	995-1002	However	_
8-2	1003-1004	,	_
8-3	1005-1008	the	_
8-4	1009-1012	CHR	http://maven.renci.org/NeuroBridge/neurobridge#ChronicPain
8-5	1013-1018	group	_
8-6	1019-1031	consistently	_
8-7	1032-1041	performed	_
8-8	1042-1046	more	_
8-9	1047-1053	poorly	_
8-10	1054-1059	under	_
8-11	1060-1069	dual-task	_
8-12	1070-1080	conditions	_
8-13	1081-1082	,	_
8-14	1083-1086	and	_
8-15	1087-1096	exhibited	_
8-16	1097-1098	a	_
8-17	1099-1105	higher	_
8-18	1106-1115	dual-task	_
8-19	1116-1120	cost	_
8-20	1121-1126	after	_
8-21	1127-1135	learning	_
8-22	1136-1137	.	_

9-1	1138-1145	Further	_
9-2	1146-1147	,	_
9-3	1148-1156	learning	_
9-4	1157-1161	rate	_
9-5	1162-1164	in	_
9-6	1165-1168	the	_
9-7	1169-1172	CHR	http://maven.renci.org/NeuroBridge/neurobridge#ChronicPain
9-8	1173-1178	group	_
9-9	1179-1182	was	_
9-10	1183-1196	significantly	_
9-11	1197-1207	associated	_
9-12	1208-1212	with	_
9-13	1213-1220	symptom	_
9-14	1221-1229	severity	_
9-15	1230-1231	.	_

10-1	1232-1236	Both	_
10-2	1237-1243	groups	_
10-3	1244-1250	showed	_
10-4	1251-1261	activation	_
10-5	1262-1264	in	_
10-6	1265-1272	regions	_
10-7	1273-1275	of	_
10-8	1276-1279	the	_
10-9	1280-1284	CTCC	_
10-10	1285-1286	.	_

11-1	1287-1293	During	_
11-2	1294-1299	early	_
11-3	1300-1308	learning	_
11-4	1309-1310	,	_
11-5	1311-1314	the	_
11-6	1315-1318	CHR	http://maven.renci.org/NeuroBridge/neurobridge#ParallelGroupTrial
11-7	1319-1324	group	http://maven.renci.org/NeuroBridge/neurobridge#ParallelGroupTrial
11-8	1325-1334	exhibited	_
11-9	1335-1342	greater	_
11-10	1343-1353	engagement	_
11-11	1354-1356	of	_
11-12	1357-1364	regions	_
11-13	1365-1367	of	_
11-14	1368-1371	the	_
11-15	1372-1379	default	_
11-16	1380-1384	mode	_
11-17	1385-1392	network	_
11-18	1393-1394	,	_
11-19	1395-1405	suggesting	_
11-20	1406-1410	that	_
11-21	1411-1415	they	_
11-22	1416-1420	were	_
11-23	1421-1425	less	_
11-24	1426-1430	able	_
11-25	1431-1433	to	_
11-26	1434-1440	engage	_
11-27	1441-1444	the	_
11-28	1445-1456	appropriate	_
11-29	1457-1461	task	_
11-30	1462-1470	positive	_
11-31	1471-1479	networks	_
11-32	1480-1481	.	_

12-1	1482-1488	During	_
12-2	1489-1493	late	_
12-3	1494-1502	learning	_
12-4	1503-1504	,	_
12-5	1505-1510	there	_
12-6	1511-1515	were	_
12-7	1516-1527	qualitative	_
12-8	1528-1539	differences	_
12-9	1540-1547	wherein	_
12-10	1548-1556	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
12-11	1557-1563	showed	_
12-12	1564-1568	more	_
12-13	1569-1579	prefrontal	_
12-14	1580-1588	cortical	_
12-15	1589-1599	activation	_
12-16	1600-1601	.	_

13-1	1602-1608	Higher	_
13-2	1609-1614	order	_
13-3	1615-1624	cognitive	_
13-4	1625-1629	rule	_
13-5	1630-1638	learning	_
13-6	1639-1641	is	_
13-7	1642-1649	related	_
13-8	1650-1652	to	_
13-9	1653-1660	symptom	_
13-10	1661-1669	severity	_
13-11	1670-1672	in	_
13-12	1673-1676	CHR	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceDisorderStatus
13-13	1677-1688	individuals	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceDisorderStatus
13-14	1689-1690	.	_

14-1	1691-1695	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
14-2	1696-1704	revealed	_
14-3	1705-1709	that	_
14-4	1710-1713	CHR	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceDisorderStatus
14-5	1714-1725	individuals	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceDisorderStatus
14-6	1726-1729	may	_
14-7	1730-1733	not	_
14-8	1734-1742	reliably	_
14-9	1743-1752	disengage	_
14-10	1753-1756	the	_
14-11	1757-1764	default	_
14-12	1765-1769	mode	_
14-13	1770-1777	network	_
14-14	1778-1779	,	_
14-15	1780-1783	and	_
14-16	1784-1790	during	_
14-17	1791-1795	late	_
14-18	1796-1804	learning	_
14-19	1805-1814	high-risk	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk
14-20	1815-1820	youth	_
14-21	1821-1824	may	_
14-22	1825-1828	not	_
14-23	1829-1835	engage	_
14-24	1836-1839	the	_
14-25	1840-1850	prefrontal	_
14-26	1851-1857	cortex	_
14-27	1858-1860	as	_
14-28	1861-1872	extensively	_
14-29	1873-1875	as	_
14-30	1876-1884	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
14-31	1885-1886	.	_

15-1	1887-1897	Highlights	_
15-2	1898-1903	There	_
15-3	1904-1907	are	_
15-4	1908-1911	few	_
15-5	1912-1916	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
15-6	1917-1924	studies	_
15-7	1925-1927	in	_
15-8	1928-1933	youth	_
15-9	1934-1936	at	_
15-10	1937-1945	clinical	_
15-11	1946-1955	high-risk	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk
15-12	1956-1957	(	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk
15-13	1958-1961	CHR	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk
15-14	1962-1963	)	_
15-15	1964-1966	of	_
15-16	1967-1976	psychosis	_
15-17	1977-1978	.	_

16-1	1979-1983	This	_
16-2	1984-1986	is	_
16-3	1987-1990	the	_
16-4	1991-1996	first	_
16-5	1997-2007	task-based	_
16-6	2008-2012	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
16-7	2013-2018	study	_
16-8	2019-2021	of	_
16-9	2022-2025	the	_
16-10	2026-2036	cerebellum	_
16-11	2037-2039	in	_
16-12	2040-2041	a	_
16-13	2042-2045	CHR	_
16-14	2046-2056	population	_
16-15	2057-2058	.	_

17-1	2059-2062	CHR	_
17-2	2063-2068	learn	_
17-3	2069-2071	at	_
17-4	2072-2073	a	_
17-5	2074-2081	similar	_
17-6	2082-2086	rate	_
17-7	2087-2088	,	_
17-8	2089-2092	but	_
17-9	2093-2096	not	_
17-10	2097-2099	as	_
17-11	2100-2104	well	_
17-12	2105-2106	,	_
17-13	2107-2109	as	_
17-14	2110-2117	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
17-15	2118-2126	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
17-16	2127-2128	.	_

18-1	2129-2137	Learning	_
18-2	2138-2142	rate	_
18-3	2143-2145	is	_
18-4	2146-2153	related	_
18-5	2154-2156	to	_
18-6	2157-2169	disorganized	_
18-7	2170-2177	symptom	_
18-8	2178-2186	severity	_
18-9	2187-2189	in	_
18-10	2190-2193	the	_
18-11	2194-2197	CHR	http://maven.renci.org/NeuroBridge/neurobridge#ChronicPain
18-12	2198-2203	group	_
18-13	2204-2205	.	_

19-1	2206-2209	The	_
19-2	2210-2216	groups	_
19-3	2217-2223	engage	_
19-4	2224-2250	cerebello-thalamo-cortical	_
19-5	2251-2259	circuits	_
19-6	2260-2271	differently	_
19-7	2272-2278	during	_
19-8	2279-2287	learning	_
19-9	2288-2289	.	_

20-1	2290-2297	Methods	_
20-2	2298-2310	Participants	_
20-3	2311-2315	Here	_
20-4	2316-2317	,	_
20-5	2318-2320	we	_
20-6	2321-2333	investigated	_
20-7	2334-2336	20	_
20-8	2337-2347	adolescent	http://maven.renci.org/NeuroBridge/neurobridge#DataCollectionInstrument
20-9	2348-2351	and	_
20-10	2352-2357	young	_
20-11	2358-2363	adult	http://maven.renci.org/NeuroBridge/neurobridge#NationalAdultReadingTest
20-12	2364-2367	CHR	http://maven.renci.org/NeuroBridge/neurobridge#NationalAdultReadingTest
20-13	2368-2379	individuals	http://maven.renci.org/NeuroBridge/neurobridge#NationalAdultReadingTest
20-14	2380-2381	(	_
20-15	2382-2386	mean	_
20-16	2387-2390	age	_
20-17	2391-2392	=	_
20-18	2393-2397	20.8	_
20-19	2398-2399	±	_
20-20	2400-2404	1.54	_
20-21	2405-2410	years	_
20-22	2411-2412	,	_
20-23	2413-2414	7	_
20-24	2415-2421	female	_
20-25	2422-2423	)	_
20-26	2424-2425	,	_
20-27	2426-2429	and	_
20-28	2430-2432	21	_
20-29	2433-2440	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
20-30	2441-2449	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
20-31	2450-2451	(	_
20-32	2452-2456	mean	_
20-33	2457-2460	age	_
20-34	2461-2462	=	_
20-35	2463-2467	21.5	_
20-36	2468-2469	±	_
20-37	2470-2474	1.83	_
20-38	2475-2480	years	_
20-39	2481-2482	,	_
20-40	2483-2485	11	_
20-41	2486-2492	female	_
20-42	2493-2494	)	_
20-43	2495-2496	.	_

21-1	2497-2500	See	_
21-2	2501-2506	Table	_
21-3	2507-2508	1	_
21-4	2509-2512	for	_
21-5	2513-2524	demographic	_
21-6	2525-2536	information	_
21-7	2537-2538	.	_

22-1	2539-2542	All	_
22-2	2543-2555	participants	_
22-3	2556-2559	had	_
22-4	2560-2570	previously	_
22-5	2571-2579	enrolled	_
22-6	2580-2582	in	_
22-7	2583-2584	a	_
22-8	2585-2597	longitudinal	_
22-9	2598-2603	study	_
22-10	2604-2617	investigating	_
22-11	2618-2627	psychosis	_
22-12	2628-2632	risk	_
22-13	2633-2635	as	_
22-14	2636-2640	part	_
22-15	2641-2643	of	_
22-16	2644-2647	the	_
22-17	2648-2658	Adolescent	_
22-18	2659-2670	Development	_
22-19	2671-2674	and	_
22-20	2675-2687	Preventative	http://maven.renci.org/NeuroBridge/neurobridge#TreatmentResponseProgressScale
22-21	2688-2697	Treatment	http://maven.renci.org/NeuroBridge/neurobridge#TreatmentResponseProgressScale
22-22	2698-2699	(	http://maven.renci.org/NeuroBridge/neurobridge#TreatmentResponseProgressScale
22-23	2700-2705	ADAPT	http://maven.renci.org/NeuroBridge/neurobridge#TreatmentResponseProgressScale
22-24	2706-2707	)	http://maven.renci.org/NeuroBridge/neurobridge#TreatmentResponseProgressScale
22-25	2708-2716	research	_
22-26	2717-2724	program	_
22-27	2725-2727	at	_
22-28	2728-2731	the	_
22-29	2732-2742	University	_
22-30	2743-2745	of	_
22-31	2746-2754	Colorado	_
22-32	2755-2762	Boulder	_
22-33	2763-2764	.	_

23-1	2765-2777	Participants	_
23-2	2778-2782	were	_
23-3	2783-2792	recruited	_
23-4	2793-2796	for	_
23-5	2797-2810	participation	_
23-6	2811-2813	in	_
23-7	2814-2818	this	_
23-8	2819-2832	investigation	_
23-9	2833-2835	at	_
23-10	2836-2839	the	_
23-11	2840-2843	end	_
23-12	2844-2846	of	_
23-13	2847-2852	their	_
23-14	2853-2859	annual	_
23-15	2860-2865	study	_
23-16	2866-2871	visit	_
23-17	2872-2873	,	_
23-18	2874-2876	or	_
23-19	2877-2881	were	_
23-20	2882-2890	directly	_
23-21	2891-2900	contacted	_
23-22	2901-2905	over	_
23-23	2906-2909	the	_
23-24	2910-2915	phone	_
23-25	2916-2917	.	_

24-1	2918-2923	Prior	_
24-2	2924-2926	to	_
24-3	2927-2936	beginning	_
24-4	2937-2940	the	_
24-5	2941-2946	study	_
24-6	2947-2950	all	_
24-7	2951-2963	participants	_
24-8	2964-2970	signed	_
24-9	2971-2973	an	_
24-10	2974-2986	IRB-approved	_
24-11	2987-2994	consent	_
24-12	2995-2999	form	_
24-13	3000-3001	.	_

25-1	3002-3011	Exclusion	_
25-2	3012-3020	criteria	_
25-3	3021-3024	for	_
25-4	3025-3029	both	_
25-5	3030-3036	groups	_
25-6	3037-3045	included	_
25-7	3046-3047	a	_
25-8	3048-3055	history	_
25-9	3056-3058	of	_
25-10	3059-3063	head	_
25-11	3064-3070	injury	_
25-12	3071-3072	,	_
25-13	3073-3076	the	_
25-14	3077-3085	presence	_
25-15	3086-3088	of	_
25-16	3089-3090	a	_
25-17	3091-3103	neurological	_
25-18	3104-3112	disorder	_
25-19	3113-3114	,	_
25-20	3115-3124	life-time	_
25-21	3125-3134	substance	_
25-22	3135-3145	dependence	_
25-23	3146-3148	as	_
25-24	3149-3157	assessed	_
25-25	3158-3160	by	_
25-26	3161-3164	the	_
25-27	3165-3175	Structured	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
25-28	3176-3184	Clinical	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
25-29	3185-3194	Interview	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
25-30	3195-3198	for	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
25-31	3199-3205	Axis-I	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
25-32	3206-3209	DSM	_
25-33	3210-3212	IV	_
25-34	3213-3222	Disorders	_
25-35	3223-3224	,	_
25-36	3225-3228	and	_
25-37	3229-3232	the	_
25-38	3233-3241	presence	_
25-39	3242-3244	of	_
25-40	3245-3248	any	_
25-41	3249-3266	contraindications	_
25-42	3267-3270	for	_
25-43	3271-3274	the	_
25-44	3275-3283	magnetic	_
25-45	3284-3293	resonance	_
25-46	3294-3301	imaging	_
25-47	3302-3313	environment	_
25-48	3314-3315	.	_

26-1	3316-3318	In	_
26-2	3319-3322	the	_
26-3	3323-3326	CHR	_
26-4	3327-3332	group	_
26-5	3333-3334	,	_
26-6	3335-3337	we	_
26-7	3338-3342	also	_
26-8	3343-3351	excluded	_
26-9	3352-3363	individuals	_
26-10	3364-3368	with	_
26-11	3369-3371	an	_
26-12	3372-3376	Axis	_
26-13	3377-3378	I	_
26-14	3379-3388	psychotic	_
26-15	3389-3397	disorder	_
26-16	3398-3399	.	_

27-1	3400-3402	In	_
27-2	3403-3406	the	_
27-3	3407-3414	control	_
27-4	3415-3421	sample	_
27-5	3422-3423	,	_
27-6	3424-3426	we	_
27-7	3427-3435	excluded	_
27-8	3436-3447	individuals	_
27-9	3448-3452	with	_
27-10	3453-3456	any	_
27-11	3457-3466	diagnosis	_
27-12	3467-3469	of	_
27-13	3470-3472	an	_
27-14	3473-3477	Axis	_
27-15	3478-3479	I	_
27-16	3480-3488	disorder	_
27-17	3489-3490	.	_

28-1	3491-3498	Further	_
28-2	3499-3500	,	_
28-3	3501-3504	the	_
28-4	3505-3513	presence	_
28-5	3514-3516	of	_
28-6	3517-3518	a	_
28-7	3519-3528	psychotic	_
28-8	3529-3537	disorder	_
28-9	3538-3540	in	_
28-10	3541-3553	first-degree	_
28-11	3554-3563	relatives	_
28-12	3564-3567	was	_
28-13	3568-3570	an	_
28-14	3571-3581	additional	_
28-15	3582-3591	exclusion	_
28-16	3592-3601	criterion	_
28-17	3602-3605	for	_
28-18	3606-3609	the	_
28-19	3610-3617	control	_
28-20	3618-3623	group	_
28-21	3624-3625	.	_

29-1	3626-3633	Symptom	_
29-2	3634-3644	assessment	_
29-3	3645-3648	The	_
29-4	3649-3659	Structured	http://maven.renci.org/NeuroBridge/neurobridge#StructuredInterviewforProdromalSyndromesRatingScale
29-5	3660-3669	Interview	http://maven.renci.org/NeuroBridge/neurobridge#StructuredInterviewforProdromalSyndromesRatingScale
29-6	3670-3673	for	http://maven.renci.org/NeuroBridge/neurobridge#StructuredInterviewforProdromalSyndromesRatingScale
29-7	3674-3683	Prodromal	http://maven.renci.org/NeuroBridge/neurobridge#StructuredInterviewforProdromalSyndromesRatingScale
29-8	3684-3693	Syndromes	http://maven.renci.org/NeuroBridge/neurobridge#StructuredInterviewforProdromalSyndromesRatingScale
29-9	3694-3695	(	http://maven.renci.org/NeuroBridge/neurobridge#StructuredInterviewforProdromalSyndromesRatingScale
29-10	3696-3700	SIPS	_
29-11	3701-3702	)	http://maven.renci.org/NeuroBridge/neurobridge#Thing
29-12	3703-3711	measures	_
29-13	3712-3720	distinct	_
29-14	3721-3731	categories	_
29-15	3732-3734	of	_
29-16	3735-3744	prodromal	_
29-17	3745-3752	symptom	_
29-18	3753-3760	domains	_
29-19	3761-3762	(	_
29-20	3763-3771	positive	_
29-21	3772-3773	,	_
29-22	3774-3782	negative	_
29-23	3783-3784	,	_
29-24	3785-3797	disorganized	_
29-25	3798-3799	,	_
29-26	3800-3807	general	_
29-27	3808-3809	)	_
29-28	3810-3813	and	_
29-29	3814-3816	is	_
29-30	3817-3823	scored	_
29-31	3824-3828	from	_
29-32	3829-3830	0	_
29-33	3831-3833	to	_
29-34	3834-3835	6	_
29-35	3836-3839	for	_
29-36	3840-3844	each	_
29-37	3845-3852	symptom	_
29-38	3853-3854	.	_

30-1	3855-3864	Inclusion	_
30-2	3865-3867	in	_
30-3	3868-3871	the	_
30-4	3872-3875	CHR	_
30-5	3876-3881	group	_
30-6	3882-3885	was	_
30-7	3886-3896	determined	_
30-8	3897-3899	by	_
30-9	3900-3908	moderate	_
30-10	3909-3915	levels	_
30-11	3916-3918	of	_
30-12	3919-3927	positive	_
30-13	3928-3936	symptoms	_
30-14	3937-3938	(	_
30-15	3939-3940	a	_
30-16	3941-3945	SIPS	_
30-17	3946-3951	score	_
30-18	3952-3954	of	_
30-19	3955-3958	3–5	_
30-20	3959-3961	in	_
30-21	3962-3965	one	_
30-22	3966-3968	or	_
30-23	3969-3973	more	_
30-24	3974-3976	of	_
30-25	3977-3980	the	_
30-26	3981-3982	5	_
30-27	3983-3991	positive	_
30-28	3992-3999	symptom	_
30-29	4000-4010	categories	_
30-30	4011-4012	)	_
30-31	4013-4014	,	_
30-32	4015-4021	and/or	_
30-33	4022-4023	a	_
30-34	4024-4031	decline	_
30-35	4032-4034	in	_
30-36	4035-4041	global	_
30-37	4042-4053	functioning	_
30-38	4054-4056	in	_
30-39	4057-4068	association	_
30-40	4069-4073	with	_
30-41	4074-4077	the	_
30-42	4078-4086	presence	_
30-43	4087-4089	of	_
30-44	4090-4101	schizotypal	_
30-45	4102-4113	personality	_
30-46	4114-4122	disorder	_
30-47	4123-4124	,	_
30-48	4125-4131	and/or	_
30-49	4132-4133	a	_
30-50	4134-4140	family	_
30-51	4141-4148	history	_
30-52	4149-4151	of	_
30-53	4152-4165	schizophrenia	_
30-54	4166-4167	.	_

31-1	4168-4171	All	_
31-2	4172-4184	interviewers	_
31-3	4185-4188	had	_
31-4	4189-4200	inter-rater	_
31-5	4201-4214	reliabilities	_
31-6	4215-4219	that	_
31-7	4220-4228	exceeded	_
31-8	4229-4234	Kappa	_
31-9	4235-4238	≥80	_
31-10	4239-4240	.	_

32-1	4241-4248	Because	_
32-2	4249-4251	we	_
32-3	4252-4256	were	_
32-4	4257-4267	recruiting	_
32-5	4268-4280	participants	_
32-6	4281-4285	from	_
32-7	4286-4288	an	_
32-8	4289-4296	ongoing	_
32-9	4297-4302	study	_
32-10	4303-4304	,	_
32-11	4305-4307	if	_
32-12	4308-4311	the	_
32-13	4312-4322	individual	_
32-14	4323-4326	had	_
32-15	4327-4331	been	_
32-16	4332-4344	administered	_
32-17	4345-4348	the	_
32-18	4349-4353	SIPS	_
32-19	4354-4355	(	_
32-20	4356-4359	and	_
32-21	4360-4367	SCID-IV	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
32-22	4368-4369	)	_
32-23	4370-4376	within	_
32-24	4377-4380	one	_
32-25	4381-4386	month	_
32-26	4387-4392	prior	_
32-27	4393-4395	to	_
32-28	4396-4399	the	_
32-29	4400-4404	scan	_
32-30	4405-4406	,	_
32-31	4407-4412	those	_
32-32	4413-4424	assessments	_
32-33	4425-4429	were	_
32-34	4430-4434	used	_
32-35	4435-4437	to	_
32-36	4438-4446	minimize	_
32-37	4447-4458	participant	_
32-38	4459-4465	burden	_
32-39	4466-4467	.	_

33-1	4468-4471	For	_
33-2	4472-4477	those	_
33-3	4478-4482	with	_
33-4	4483-4494	assessments	_
33-5	4495-4499	over	_
33-6	4500-4503	one	_
33-7	4504-4509	month	_
33-8	4510-4514	from	_
33-9	4515-4518	the	_
33-10	4519-4523	time	_
33-11	4524-4526	of	_
33-12	4527-4531	scan	_
33-13	4532-4533	,	_
33-14	4534-4545	individuals	_
33-15	4546-4555	underwent	_
33-16	4556-4558	an	_
33-17	4559-4569	additional	_
33-18	4570-4578	clinical	_
33-19	4579-4588	interview	_
33-20	4589-4590	.	_

34-1	4591-4594	The	_
34-2	4595-4604	frequency	_
34-3	4605-4607	of	_
34-4	4608-4615	alcohol	_
34-5	4616-4619	and	_
34-6	4620-4629	marijuana	_
34-7	4630-4641	consumption	_
34-8	4642-4645	was	_
34-9	4646-4654	measured	_
34-10	4655-4660	based	_
34-11	4661-4663	on	_
34-12	4664-4675	self-report	_
34-13	4676-4678	on	_
34-14	4679-4680	a	_
34-15	4681-4686	scale	_
34-16	4687-4691	from	_
34-17	4692-4693	0	_
34-18	4694-4696	to	_
34-19	4697-4698	5	_
34-20	4699-4704	where	_
34-21	4705-4706	0	_
34-22	4707-4716	indicates	_
34-23	4717-4718	“	_
34-24	4719-4724	never	_
34-25	4725-4729	uses	_
34-26	4730-4731	”	_
34-27	4732-4735	and	_
34-28	4736-4737	5	_
34-29	4738-4747	indicates	_
34-30	4748-4749	“	_
34-31	4750-4755	daily	_
34-32	4756-4759	use	_
34-33	4760-4761	”	_
34-34	4762-4763	.	_

35-1	4764-4776	Second-order	_
35-2	4777-4781	rule	_
35-3	4782-4790	learning	_
35-4	4791-4795	task	_
35-5	4796-4798	In	_
35-6	4799-4804	order	_
35-7	4805-4807	to	_
35-8	4808-4814	assess	_
35-9	4815-4824	non-motor	_
35-10	4825-4829	rule	_
35-11	4830-4838	learning	_
35-12	4839-4844	while	_
35-13	4845-4854	targeting	_
35-14	4855-4858	the	_
35-15	4859-4863	CTCC	_
35-16	4864-4865	,	_
35-17	4866-4868	we	_
35-18	4869-4873	used	_
35-19	4874-4875	a	_
35-20	4876-4888	second-order	_
35-21	4889-4893	rule	http://maven.renci.org/NeuroBridge/neurobridge#II
35-22	4894-4902	learning	http://maven.renci.org/NeuroBridge/neurobridge#II
35-23	4903-4907	task	http://maven.renci.org/NeuroBridge/neurobridge#II
35-24	4908-4917	developed	_
35-25	4918-4920	by	_
35-26	4921-4922	.	_

36-1	4923-4927	This	_
36-2	4928-4932	task	_
36-3	4933-4936	was	_
36-4	4937-4945	designed	_
36-5	4946-4948	to	_
36-6	4949-4959	dissociate	_
36-7	4960-4963	the	_
36-8	4964-4971	motoric	_
36-9	4972-4980	response	_
36-10	4981-4983	to	_
36-11	4984-4985	a	_
36-12	4986-4992	visual	_
36-13	4993-5001	stimulus	_
36-14	5002-5006	from	_
36-15	5007-5010	the	_
36-16	5011-5024	rule-learning	_
36-17	5025-5031	itself	_
36-18	5032-5033	.	_

37-1	5034-5036	To	_
37-2	5037-5039	do	_
37-3	5040-5042	so	_
37-4	5043-5044	,	_
37-5	5045-5047	we	_
37-6	5048-5052	used	_
37-7	5053-5055	an	_
37-8	5056-5069	event-related	_
37-9	5070-5077	imaging	_
37-10	5078-5084	design	_
37-11	5085-5086	(	_
37-12	5087-5096	described	_
37-13	5097-5099	in	_
37-14	5100-5104	more	_
37-15	5105-5111	detail	_
37-16	5112-5117	below	_
37-17	5118-5119	)	_
37-18	5120-5127	wherein	_
37-19	5128-5130	we	_
37-20	5131-5135	were	_
37-21	5136-5140	able	_
37-22	5141-5143	to	_
37-23	5144-5154	dissociate	_
37-24	5155-5158	the	_
37-25	5159-5169	activation	_
37-26	5170-5180	associated	_
37-27	5181-5185	with	_
37-28	5186-5189	the	_
37-29	5190-5194	rule	_
37-30	5195-5201	itself	_
37-31	5202-5203	,	_
37-32	5204-5208	from	_
37-33	5209-5213	that	_
37-34	5214-5224	associated	_
37-35	5225-5229	with	_
37-36	5230-5233	the	_
37-37	5234-5245	preparation	_
37-38	5246-5249	and	_
37-39	5250-5259	execution	_
37-40	5260-5262	of	_
37-41	5263-5266	the	_
37-42	5267-5272	motor	_
37-43	5273-5281	response	_
37-44	5282-5283	.	_

38-1	5284-5291	Because	_
38-2	5292-5294	we	_
38-3	5295-5299	were	_
38-4	5300-5312	particularly	_
38-5	5313-5323	interested	_
38-6	5324-5326	in	_
38-7	5327-5337	cerebellar	_
38-8	5338-5348	activation	_
38-9	5349-5355	during	_
38-10	5356-5364	learning	_
38-11	5365-5367	in	_
38-12	5368-5369	a	_
38-13	5370-5379	non-motor	_
38-14	5380-5388	paradigm	_
38-15	5389-5391	in	_
38-16	5392-5395	CHR	http://maven.renci.org/NeuroBridge/neurobridge#ChronicPain
38-17	5396-5407	individuals	_
38-18	5408-5409	,	_
38-19	5410-5412	we	_
38-20	5413-5420	adapted	_
38-21	5421-5424	the	_
38-22	5425-5437	second-order	_
38-23	5438-5442	rule	_
38-24	5443-5451	learning	_
38-25	5452-5461	condition	_
38-26	5462-5464	to	_
38-27	5465-5476	investigate	_
38-28	5477-5482	group	_
38-29	5483-5494	differences	_
38-30	5495-5497	in	_
38-31	5498-5508	cerebellar	_
38-32	5509-5519	activation	_
38-33	5520-5526	during	_
38-34	5527-5535	learning	_
38-35	5536-5537	.	_

39-1	5538-5540	In	_
39-2	5541-5546	order	_
39-3	5547-5549	to	_
39-4	5550-5555	focus	_
39-5	5556-5558	on	_
39-6	5559-5567	learning	_
39-7	5568-5570	of	_
39-8	5571-5574	the	_
39-9	5575-5587	associations	_
39-10	5588-5592	over	_
39-11	5593-5597	time	_
39-12	5598-5599	,	_
39-13	5600-5602	we	_
39-14	5603-5610	adapted	_
39-15	5611-5614	the	_
39-16	5615-5619	task	_
39-17	5620-5624	such	_
39-18	5625-5629	that	_
39-19	5630-5642	participants	_
39-20	5643-5652	completed	_
39-21	5653-5654	6	_
39-22	5655-5661	blocks	_
39-23	5662-5664	of	_
39-24	5665-5673	learning	_
39-25	5674-5675	,	_
39-26	5676-5683	whereas	_
39-27	5684-5685	,	_
39-28	5686-5690	also	_
39-29	5691-5699	included	_
39-30	5700-5707	several	_
39-31	5708-5718	additional	_
39-32	5719-5729	conditions	_
39-33	5730-5731	,	_
39-34	5732-5741	including	_
39-35	5742-5743	a	_
39-36	5744-5755	first-order	_
39-37	5756-5760	rule	_
39-38	5761-5762	.	_

40-1	5763-5767	Just	_
40-2	5768-5776	learning	_
40-3	5777-5783	blocks	_
40-4	5784-5789	allow	_
40-5	5790-5793	for	_
40-6	5794-5797	the	_
40-7	5798-5808	collection	_
40-8	5809-5811	of	_
40-9	5812-5818	enough	_
40-10	5819-5823	data	_
40-11	5824-5826	to	_
40-12	5827-5831	look	_
40-13	5832-5834	at	_
40-14	5835-5840	early	_
40-15	5841-5847	versus	_
40-16	5848-5852	late	_
40-17	5853-5861	learning	_
40-18	5862-5863	,	_
40-19	5864-5867	and	_
40-20	5868-5870	to	_
40-21	5871-5876	asses	_
40-22	5877-5882	group	_
40-23	5883-5894	differences	_
40-24	5895-5897	in	_
40-25	5898-5902	both	_
40-26	5903-5911	behavior	_
40-27	5912-5915	and	_
40-28	5916-5921	brain	_
40-29	5922-5932	activation	_
40-30	5933-5939	during	_
40-31	5940-5945	these	_
40-32	5946-5952	phases	_
40-33	5953-5954	.	_

41-1	5955-5962	Further	_
41-2	5963-5964	,	_
41-3	5965-5967	we	_
41-4	5968-5976	modified	_
41-5	5977-5981	this	_
41-6	5982-5986	task	_
41-7	5987-5995	slightly	_
41-8	5996-5998	in	_
41-9	5999-6004	terms	_
41-10	6005-6007	of	_
41-11	6008-6014	timing	_
41-12	6015-6017	to	_
41-13	6018-6022	work	_
41-14	6023-6027	with	_
41-15	6028-6038	multi-band	_
41-16	6039-6046	imaging	_
41-17	6047-6048	,	_
41-18	6049-6052	but	_
41-19	6053-6057	were	_
41-20	6058-6065	careful	_
41-21	6066-6068	to	_
41-22	6069-6073	keep	_
41-23	6074-6078	task	_
41-24	6079-6085	timing	_
41-25	6086-6088	as	_
41-26	6089-6094	close	_
41-27	6095-6097	to	_
41-28	6098-6101	the	_
41-29	6102-6110	original	_
41-30	6111-6119	paradigm	_
41-31	6120-6122	as	_
41-32	6123-6131	possible	_
41-33	6132-6133	(	_
41-34	6134-6140	timing	_
41-35	6141-6148	details	_
41-36	6149-6158	described	_
41-37	6159-6164	below	_
41-38	6165-6166	)	_
41-39	6167-6168	.	_

42-1	6169-6181	Participants	_
42-2	6182-6186	were	_
42-3	6187-6197	instructed	_
42-4	6198-6200	to	_
42-5	6201-6206	match	_
42-6	6207-6209	an	_
42-7	6210-6218	abstract	_
42-8	6219-6224	shape	_
42-9	6225-6229	with	_
42-10	6230-6231	a	_
42-11	6232-6237	color	_
42-12	6238-6239	.	_

43-1	6240-6245	There	_
43-2	6246-6250	were	_
43-3	6251-6255	four	_
43-4	6256-6262	colors	_
43-5	6263-6266	and	_
43-6	6267-6271	four	_
43-7	6272-6278	shapes	_
43-8	6279-6280	.	_

44-1	6281-6288	Initial	_
44-2	6289-6298	responses	_
44-3	6299-6303	were	_
44-4	6304-6308	made	_
44-5	6309-6311	by	_
44-6	6312-6320	guessing	_
44-7	6321-6322	.	_

45-1	6323-6335	Participants	_
45-2	6336-6344	received	_
45-3	6345-6353	feedback	_
45-4	6354-6359	about	_
45-5	6360-6365	their	_
45-6	6366-6377	performance	_
45-7	6378-6383	after	_
45-8	6384-6390	making	_
45-9	6391-6396	their	_
45-10	6397-6406	responses	_
45-11	6407-6408	.	_

46-1	6409-6415	During	_
46-2	6416-6419	the	_
46-3	6420-6424	task	_
46-4	6425-6426	,	_
46-5	6427-6439	participants	_
46-6	6440-6444	were	_
46-7	6445-6454	presented	_
46-8	6455-6459	with	_
46-9	6460-6462	an	_
46-10	6463-6471	abstract	_
46-11	6472-6477	shape	_
46-12	6478-6480	in	_
46-13	6481-6486	green	_
46-14	6487-6488	,	_
46-15	6489-6491	on	_
46-16	6492-6493	a	_
46-17	6494-6498	grey	_
46-18	6499-6509	background	_
46-19	6510-6513	for	_
46-20	6514-6517	460	_
46-21	6518-6520	ms	_
46-22	6521-6522	(	_
46-23	6523-6524	“	_
46-24	6525-6536	instruction	_
46-25	6537-6540	cue	_
46-26	6541-6542	”	_
46-27	6543-6544	)	_
46-28	6545-6546	,	_
46-29	6547-6551	with	_
46-30	6552-6556	four	_
46-31	6557-6563	blanks	_
46-32	6564-6569	below	_
46-33	6570-6572	it	_
46-34	6573-6574	,	_
46-35	6575-6585	indicative	_
46-36	6586-6588	of	_
46-37	6589-6592	the	_
46-38	6593-6600	buttons	_
46-39	6601-6603	to	_
46-40	6604-6606	be	_
46-41	6607-6611	used	_
46-42	6612-6615	for	_
46-43	6616-6626	responding	_
46-44	6627-6628	.	_

47-1	6629-6633	This	_
47-2	6634-6637	was	_
47-3	6638-6642	both	_
47-4	6643-6651	preceded	_
47-5	6652-6655	and	_
47-6	6656-6664	followed	_
47-7	6665-6667	by	_
47-8	6668-6669	a	_
47-9	6670-6678	variable	_
47-10	6679-6684	delay	_
47-11	6685-6686	.	_

48-1	6687-6692	After	_
48-2	6693-6696	the	_
48-3	6697-6702	delay	_
48-4	6703-6704	,	_
48-5	6705-6717	participants	_
48-6	6718-6722	were	_
48-7	6723-6732	presented	_
48-8	6733-6737	with	_
48-9	6738-6741	the	_
48-10	6742-6746	word	_
48-11	6747-6748	“	_
48-12	6749-6751	Go	_
48-13	6752-6753	!	_
48-14	6754-6755	”	_
48-15	6756-6763	written	_
48-16	6764-6766	in	_
48-17	6767-6770	red	_
48-18	6771-6773	on	_
48-19	6774-6775	a	_
48-20	6776-6780	grey	_
48-21	6781-6791	background	_
48-22	6792-6795	for	_
48-23	6796-6799	230	_
48-24	6800-6802	ms	_
48-25	6803-6804	,	_
48-26	6805-6808	and	_
48-27	6809-6813	were	_
48-28	6814-6824	instructed	_
48-29	6825-6827	to	_
48-30	6828-6832	make	_
48-31	6833-6834	a	_
48-32	6835-6847	button-press	_
48-33	6848-6856	response	_
48-34	6857-6866	following	_
48-35	6867-6870	the	_
48-36	6871-6874	cue	_
48-37	6875-6876	.	_

49-1	6877-6881	Next	_
49-2	6882-6883	,	_
49-3	6884-6896	participants	_
49-4	6897-6900	saw	_
49-5	6901-6905	four	_
49-6	6906-6915	hourglass	_
49-7	6916-6922	shapes	_
49-8	6923-6924	,	_
49-9	6925-6929	each	_
49-10	6930-6933	one	_
49-11	6934-6935	a	_
49-12	6936-6945	different	_
49-13	6946-6951	color	_
49-14	6952-6953	(	_
49-15	6954-6959	black	_
49-16	6960-6961	,	_
49-17	6962-6966	blue	_
49-18	6967-6968	,	_
49-19	6969-6973	pink	_
49-20	6974-6975	,	_
49-21	6976-6978	or	_
49-22	6979-6985	yellow	_
49-23	6986-6987	)	_
49-24	6988-6992	from	_
49-25	6993-6997	left	_
49-26	6998-7000	to	_
49-27	7001-7006	right	_
49-28	7007-7010	for	_
49-29	7011-7014	920	_
49-30	7015-7017	ms	_
49-31	7018-7019	(	_
49-32	7020-7021	“	_
49-33	7022-7030	response	_
49-34	7031-7034	cue	_
49-35	7035-7036	”	_
49-36	7037-7038	)	_
49-37	7039-7040	.	_

50-1	7041-7045	From	_
50-2	7046-7050	left	_
50-3	7051-7053	to	_
50-4	7054-7059	right	_
50-5	7060-7061	,	_
50-6	7062-7065	the	_
50-7	7066-7075	hourglass	_
50-8	7076-7082	shapes	_
50-9	7083-7095	corresponded	_
50-10	7096-7100	with	_
50-11	7101-7104	the	_
50-12	7105-7109	four	_
50-13	7110-7116	button	_
50-14	7117-7120	box	_
50-15	7121-7125	keys	_
50-16	7126-7127	.	_

51-1	7128-7135	Finally	_
51-2	7136-7137	,	_
51-3	7138-7143	after	_
51-4	7144-7147	the	_
51-5	7148-7160	presentation	_
51-6	7161-7163	of	_
51-7	7164-7167	the	_
51-8	7168-7176	response	_
51-9	7177-7180	cue	_
51-10	7181-7182	,	_
51-11	7183-7195	participants	_
51-12	7196-7200	were	_
51-13	7201-7210	presented	_
51-14	7211-7215	with	_
51-15	7216-7224	feedback	_
51-16	7225-7226	.	_

52-1	7227-7231	They	_
52-2	7232-7235	saw	_
52-3	7236-7242	either	_
52-4	7243-7244	a	_
52-5	7245-7250	green	_
52-6	7251-7257	circle	_
52-7	7258-7259	(	_
52-8	7260-7267	correct	_
52-9	7268-7276	response	_
52-10	7277-7278	)	_
52-11	7279-7280	,	_
52-12	7281-7284	red	_
52-13	7285-7291	circle	_
52-14	7292-7293	(	_
52-15	7294-7303	incorrect	_
52-16	7304-7312	response	_
52-17	7313-7314	)	_
52-18	7315-7316	,	_
52-19	7317-7319	or	_
52-20	7320-7323	the	_
52-21	7324-7328	word	_
52-22	7329-7330	“	_
52-23	7331-7337	Missed	_
52-24	7338-7339	”	_
52-25	7340-7349	presented	_
52-26	7350-7353	for	_
52-27	7354-7357	230	_
52-28	7358-7360	ms	_
52-29	7361-7362	.	_

53-1	7363-7365	If	_
53-2	7366-7378	participants	_
53-3	7379-7382	did	_
53-4	7383-7386	not	_
53-5	7387-7391	make	_
53-6	7392-7393	a	_
53-7	7394-7400	button	_
53-8	7401-7406	press	_
53-9	7407-7413	during	_
53-10	7414-7417	the	_
53-11	7418-7421	920	_
53-12	7422-7424	ms	_
53-13	7425-7426	“	_
53-14	7427-7435	response	_
53-15	7436-7439	cue	_
53-16	7440-7441	”	_
53-17	7442-7454	presentation	_
53-18	7455-7456	,	_
53-19	7457-7461	they	_
53-20	7462-7470	received	_
53-21	7471-7474	the	_
53-22	7475-7476	“	_
53-23	7477-7483	Missed	_
53-24	7484-7485	”	_
53-25	7486-7492	screen	_
53-26	7493-7494	.	_

54-1	7495-7501	Timing	_
54-2	7502-7504	of	_
54-3	7505-7508	the	_
54-4	7509-7510	“	_
54-5	7511-7513	Go	_
54-6	7514-7515	!	_
54-7	7516-7517	”	_
54-8	7518-7524	screen	_
54-9	7525-7526	,	_
54-10	7527-7535	response	_
54-11	7536-7539	cue	_
54-12	7540-7541	,	_
54-13	7542-7545	and	_
54-14	7546-7554	feedback	_
54-15	7555-7558	was	_
54-16	7559-7567	variable	_
54-17	7568-7572	over	_
54-18	7573-7574	a	_
54-19	7575-7581	period	_
54-20	7582-7584	of	_
54-21	7585-7589	3680	_
54-22	7590-7593	ms.	_
54-23	7594-7597	All	_
54-24	7598-7610	participants	_
54-25	7611-7620	completed	_
54-26	7621-7622	6	_
54-27	7623-7629	blocks	_
54-28	7630-7632	of	_
54-29	7633-7636	the	_
54-30	7637-7641	task	_
54-31	7642-7643	,	_
54-32	7644-7648	each	_
54-33	7649-7653	with	_
54-34	7654-7656	25	_
54-35	7657-7663	trials	_
54-36	7664-7665	.	_

55-1	7666-7669	The	_
55-2	7670-7678	variable	_
55-3	7679-7686	periods	_
55-4	7687-7693	during	_
55-5	7694-7698	both	_
55-6	7699-7702	the	_
55-7	7703-7710	initial	_
55-8	7711-7712	“	_
55-9	7713-7724	instruction	_
55-10	7725-7728	cue	_
55-11	7729-7730	”	_
55-12	7731-7737	period	_
55-13	7738-7741	and	_
55-14	7742-7747	later	_
55-15	7748-7754	during	_
55-16	7755-7758	the	_
55-17	7759-7760	“	_
55-18	7761-7769	response	_
55-19	7770-7771	”	_
55-20	7772-7778	period	_
55-21	7779-7783	were	_
55-22	7784-7795	implemented	_
55-23	7796-7798	so	_
55-24	7799-7801	as	_
55-25	7802-7804	to	_
55-26	7805-7810	allow	_
55-27	7811-7814	for	_
55-28	7815-7824	jittering	_
55-29	7825-7832	between	_
55-30	7833-7839	events	_
55-31	7840-7844	such	_
55-32	7845-7849	that	_
55-33	7850-7854	fMRI	_
55-34	7855-7859	data	_
55-35	7860-7865	could	_
55-36	7866-7868	be	_
55-37	7869-7877	analyzed	_
55-38	7878-7880	in	_
55-39	7881-7883	an	_
55-40	7884-7897	event-related	_
55-41	7898-7904	manner	_
55-42	7905-7906	.	_

56-1	7907-7916	Jittering	_
56-2	7917-7923	during	_
56-3	7924-7928	both	_
56-4	7929-7935	phases	_
56-5	7936-7938	of	_
56-6	7939-7942	the	_
56-7	7943-7947	task	_
56-8	7948-7951	was	_
56-9	7952-7956	done	_
56-10	7957-7961	over	_
56-11	7962-7963	a	_
56-12	7964-7970	period	_
56-13	7971-7973	of	_
56-14	7974-7978	3680	_
56-15	7979-7981	ms	_
56-16	7982-7983	(	_
56-17	7984-7994	equivalent	_
56-18	7995-7997	to	_
56-19	7998-7999	8	_
56-20	8000-8003	TRs	_
56-21	8004-8005	)	_
56-22	8006-8007	.	_

57-1	8008-8010	In	_
57-2	8011-8021	particular	_
57-3	8022-8023	,	_
57-4	8024-8031	because	_
57-5	8032-8034	we	_
57-6	8035-8038	are	_
57-7	8039-8049	interested	_
57-8	8050-8052	in	_
57-9	8053-8056	the	_
57-10	8057-8069	second-order	_
57-11	8070-8079	non-motor	_
57-12	8080-8084	rule	_
57-13	8085-8086	,	_
57-14	8087-8091	this	_
57-15	8092-8099	allowed	_
57-16	8100-8102	us	_
57-17	8103-8105	to	_
57-18	8106-8111	focus	_
57-19	8112-8114	on	_
57-20	8115-8117	an	_
57-21	8118-8131	investigation	_
57-22	8132-8134	of	_
57-23	8135-8145	activation	_
57-24	8146-8152	during	_
57-25	8153-8156	the	_
57-26	8157-8158	“	_
57-27	8159-8170	instruction	_
57-28	8171-8174	cue	_
57-29	8175-8176	”	_
57-30	8177-8181	when	_
57-31	8182-8192	processing	_
57-32	8193-8195	is	_
57-33	8196-8198	of	_
57-34	8199-8202	the	_
57-35	8203-8207	rule	_
57-36	8208-8219	information	_
57-37	8220-8223	and	_
57-38	8224-8227	the	_
57-39	8228-8239	association	_
57-40	8240-8241	,	_
57-41	8242-8244	as	_
57-42	8245-8252	opposed	_
57-43	8253-8255	to	_
57-44	8256-8262	during	_
57-45	8263-8266	the	_
57-46	8267-8268	“	_
57-47	8269-8277	response	_
57-48	8278-8281	cue	_
57-49	8282-8283	”	_
57-50	8284-8285	,	_
57-51	8286-8291	where	_
57-52	8292-8302	processing	_
57-53	8303-8305	is	_
57-54	8306-8313	related	_
57-55	8314-8316	to	_
57-56	8317-8322	motor	_
57-57	8323-8334	preparation	_
57-58	8335-8338	and	_
57-59	8339-8348	execution	_
57-60	8349-8350	.	_

58-1	8351-8356	While	_
58-2	8357-8359	we	_
58-3	8360-8363	can	_
58-4	8364-8367	not	_
58-5	8368-8372	have	_
58-6	8373-8374	a	_
58-7	8375-8379	task	_
58-8	8380-8387	without	_
58-9	8388-8390	an	_
58-10	8391-8396	overt	_
58-11	8397-8402	motor	_
58-12	8403-8411	response	_
58-13	8412-8413	,	_
58-14	8414-8416	we	_
58-15	8417-8421	were	_
58-16	8422-8429	however	_
58-17	8430-8434	able	_
58-18	8435-8437	to	_
58-19	8438-8443	parse	_
58-20	8444-8447	the	_
58-21	8448-8458	activation	_
58-22	8459-8469	associated	_
58-23	8470-8474	with	_
58-24	8475-8484	different	_
58-25	8485-8495	components	_
58-26	8496-8498	of	_
58-27	8499-8502	the	_
58-28	8503-8507	task	_
58-29	8508-8509	,	_
58-30	8510-8514	with	_
58-31	8515-8518	the	_
58-32	8519-8526	imaging	_
58-33	8527-8533	design	_
58-34	8534-8535	,	_
58-35	8536-8546	consistent	_
58-36	8547-8551	with	_
58-37	8552-8557	prior	_
58-38	8558-8562	work	_
58-39	8563-8568	using	_
58-40	8569-8573	this	_
58-41	8574-8578	task	_
58-42	8579-8580	.	_

59-1	8581-8583	To	_
59-2	8584-8590	assess	_
59-3	8591-8594	the	_
59-4	8595-8601	degree	_
59-5	8602-8604	to	_
59-6	8605-8610	which	_
59-7	8611-8623	participants	_
59-8	8624-8631	learned	_
59-9	8632-8635	the	_
59-10	8636-8640	task	_
59-11	8641-8642	,	_
59-12	8643-8655	participants	_
59-13	8656-8660	also	_
59-14	8661-8670	completed	_
59-15	8671-8674	the	_
59-16	8675-8679	task	_
59-17	8680-8685	under	_
59-18	8686-8695	dual-task	_
59-19	8696-8706	conditions	_
59-20	8707-8711	both	_
59-21	8712-8718	before	_
59-22	8719-8722	and	_
59-23	8723-8728	after	_
59-24	8729-8732	the	_
59-25	8733-8741	learning	_
59-26	8742-8748	blocks	_
59-27	8749-8753	This	_
59-28	8754-8763	condition	_
59-29	8764-8770	served	_
59-30	8771-8773	as	_
59-31	8774-8775	a	_
59-32	8776-8788	manipulation	_
59-33	8789-8794	check	_
59-34	8795-8797	to	_
59-35	8798-8806	evaluate	_
59-36	8807-8815	learning	_
59-37	8816-8817	,	_
59-38	8818-8821	and	_
59-39	8822-8824	as	_
59-40	8825-8829	such	_
59-41	8830-8833	was	_
59-42	8834-8837	not	_
59-43	8838-8839	a	_
59-44	8840-8849	condition	_
59-45	8850-8852	of	_
59-46	8853-8861	interest	_
59-47	8862-8866	with	_
59-48	8867-8874	respect	_
59-49	8875-8877	to	_
59-50	8878-8883	brain	_
59-51	8884-8892	activity	_
59-52	8893-8894	.	_

60-1	8895-8901	During	_
60-2	8902-8905	the	_
60-3	8906-8915	dual-task	_
60-4	8916-8925	condition	_
60-5	8926-8927	,	_
60-6	8928-8931	all	_
60-7	8932-8939	aspects	_
60-8	8940-8942	of	_
60-9	8943-8946	the	_
60-10	8947-8951	task	_
60-11	8952-8960	remained	_
60-12	8961-8964	the	_
60-13	8965-8969	same	_
60-14	8970-8971	;	_
60-15	8972-8979	however	_
60-16	8980-8981	,	_
60-17	8982-8994	participants	_
60-18	8995-8999	were	_
60-19	9000-9005	asked	_
60-20	9006-9008	to	_
60-21	9009-9014	count	_
60-22	9015-9024	backwards	_
60-23	9025-9027	by	_
60-24	9028-9029	7	_
60-25	9030-9031	,	_
60-26	9032-9040	starting	_
60-27	9041-9045	from	_
60-28	9046-9049	500	_
60-29	9050-9051	.	_

61-1	9052-9056	They	_
61-2	9057-9061	were	_
61-3	9062-9067	asked	_
61-4	9068-9070	to	_
61-5	9071-9076	count	_
61-6	9077-9090	approximately	_
61-7	9091-9095	once	_
61-8	9096-9099	per	_
61-9	9100-9106	second	_
61-10	9107-9108	.	_

62-1	9109-9111	We	_
62-2	9112-9115	did	_
62-3	9116-9119	not	_
62-4	9120-9126	record	_
62-5	9127-9135	counting	_
62-6	9136-9144	accuracy	_
62-7	9145-9146	,	_
62-8	9147-9153	though	_
62-9	9154-9156	we	_
62-10	9157-9160	did	_
62-11	9161-9170	encourage	_
62-12	9171-9183	participants	_
62-13	9184-9186	to	_
62-14	9187-9195	continue	_
62-15	9196-9204	counting	_
62-16	9205-9215	throughout	_
62-17	9216-9219	the	_
62-18	9220-9224	task	_
62-19	9225-9227	in	_
62-20	9228-9231	any	_
62-21	9232-9241	instances	_
62-22	9242-9247	where	_
62-23	9248-9251	the	_
62-24	9252-9263	participant	_
62-25	9264-9270	paused	_
62-26	9271-9274	for	_
62-27	9275-9276	>	_
62-28	9277-9278	3	_
62-29	9279-9281	s.	_
62-30	9282-9284	As	_
62-31	9285-9287	we	_
62-32	9288-9292	were	_
62-33	9293-9303	interested	_
62-34	9304-9306	in	_
62-35	9307-9317	cerebellar	_
62-36	9318-9326	activity	_
62-37	9327-9333	during	_
62-38	9334-9342	learning	_
62-39	9343-9344	,	_
62-40	9345-9348	all	_
62-41	9349-9353	data	_
62-42	9354-9364	collection	_
62-43	9365-9368	was	_
62-44	9369-9378	conducted	_
62-45	9379-9381	in	_
62-46	9382-9385	the	_
62-47	9386-9389	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
62-48	9390-9401	environment	_
62-49	9402-9403	.	_

63-1	9404-9411	However	_
63-2	9412-9413	,	_
63-3	9414-9416	we	_
63-4	9417-9420	did	_
63-5	9421-9424	not	_
63-6	9425-9428	run	_
63-7	9429-9432	the	_
63-8	9433-9440	scanner	_
63-9	9441-9447	during	_
63-10	9448-9451	the	_
63-11	9452-9456	pre-	_
63-12	9457-9460	and	_
63-13	9461-9474	post-learning	_
63-14	9475-9484	dual-task	_
63-15	9485-9491	blocks	_
63-16	9492-9493	.	_

64-1	9494-9498	This	_
64-2	9499-9506	allowed	_
64-3	9507-9510	the	_
64-4	9511-9522	participant	_
64-5	9523-9525	to	_
64-6	9526-9531	speak	_
64-7	9532-9539	without	_
64-8	9540-9543	any	_
64-9	9544-9554	additional	_
64-10	9555-9561	motion	_
64-11	9562-9571	confounds	_
64-12	9572-9573	,	_
64-13	9574-9577	and	_
64-14	9578-9585	enabled	_
64-15	9586-9588	us	_
64-16	9589-9591	to	_
64-17	9592-9596	hear	_
64-18	9597-9602	their	_
64-19	9603-9609	verbal	_
64-20	9610-9618	counting	_
64-21	9619-9626	without	_
64-22	9627-9630	the	_
64-23	9631-9641	background	_
64-24	9642-9647	noise	_
64-25	9648-9650	of	_
64-26	9651-9654	the	_
64-27	9655-9662	scanner	_
64-28	9663-9664	.	_

65-1	9665-9667	We	_
65-2	9668-9678	quantified	_
65-3	9679-9687	accuracy	_
65-4	9688-9691	and	_
65-5	9692-9700	reaction	_
65-6	9701-9705	time	_
65-7	9706-9707	.	_

66-1	9708-9716	Accuracy	_
66-2	9717-9720	was	_
66-3	9721-9729	reported	_
66-4	9730-9732	as	_
66-5	9733-9736	the	_
66-6	9737-9744	percent	_
66-7	9745-9747	of	_
66-8	9748-9755	correct	_
66-9	9756-9765	responses	_
66-10	9766-9767	,	_
66-11	9768-9771	and	_
66-12	9772-9775	was	_
66-13	9776-9784	computed	_
66-14	9785-9787	on	_
66-15	9788-9789	a	_
66-16	9790-9795	block	_
66-17	9796-9798	by	_
66-18	9799-9804	block	_
66-19	9805-9810	basis	_
66-20	9811-9812	.	_

67-1	9813-9815	We	_
67-2	9816-9820	also	_
67-3	9821-9827	looked	_
67-4	9828-9830	at	_
67-5	9831-9835	both	_
67-6	9836-9838	of	_
67-7	9839-9844	these	_
67-8	9845-9854	variables	_
67-9	9855-9861	during	_
67-10	9862-9865	the	_
67-11	9866-9870	pre-	_
67-12	9871-9874	and	_
67-13	9875-9888	post-learning	_
67-14	9889-9898	dual-task	_
67-15	9899-9905	blocks	_
67-16	9906-9907	.	_

68-1	9908-9915	Finally	_
68-2	9916-9917	,	_
68-3	9918-9920	we	_
68-4	9921-9931	quantified	_
68-5	9932-9935	the	_
68-6	9936-9945	dual-task	_
68-7	9946-9950	cost	_
68-8	9951-9952	,	_
68-9	9953-9955	in	_
68-10	9956-9961	terms	_
68-11	9962-9964	of	_
68-12	9965-9973	accuracy	_
68-13	9974-9980	during	_
68-14	9981-9984	the	_
68-15	9985-9998	post-learning	_
68-16	9999-10008	dual-task	_
68-17	10009-10014	block	_
68-18	10015-10016	,	_
68-19	10017-10019	as	_
68-20	10020-10028	compared	_
68-21	10029-10031	to	_
68-22	10032-10035	the	_
68-23	10036-10044	accuracy	_
68-24	10045-10051	during	_
68-25	10052-10055	the	_
68-26	10056-10061	final	_
68-27	10062-10070	learning	_
68-28	10071-10076	block	_
68-29	10077-10078	.	_

69-1	10079-10089	Behavioral	_
69-2	10090-10101	statistical	_
69-3	10102-10110	analysis	_
69-4	10111-10122	Demographic	_
69-5	10123-10126	and	_
69-6	10127-10137	behavioral	_
69-7	10138-10147	variables	_
69-8	10148-10152	were	_
69-9	10153-10161	analyzed	_
69-10	10162-10167	using	_
69-11	10168-10171	IBM	_
69-12	10172-10176	SPSS	_
69-13	10177-10179	22	_
69-14	10180-10181	(	_
69-15	10182-10185	IBM	_
69-16	10186-10197	Corporation	_
69-17	10198-10204	Armonk	_
69-18	10205-10206	,	_
69-19	10207-10209	NY	_
69-20	10210-10211	,	_
69-21	10212-10216	2012	_
69-22	10217-10218	)	_
69-23	10219-10220	.	_

70-1	10221-10226	Group	_
70-2	10227-10238	demographic	_
70-3	10239-10250	differences	_
70-4	10251-10255	were	_
70-5	10256-10268	investigated	_
70-6	10269-10274	using	_
70-7	10275-10294	independent-samples	_
70-8	10295-10302	t-tests	_
70-9	10303-10304	.	_

71-1	10305-10307	We	_
71-2	10308-10320	investigated	_
71-3	10321-10329	accuracy	_
71-4	10330-10336	during	_
71-5	10337-10340	the	_
71-6	10341-10345	pre-	_
71-7	10346-10349	and	_
71-8	10350-10359	post-test	_
71-9	10360-10367	periods	_
71-10	10368-10370	to	_
71-11	10371-10377	ensure	_
71-12	10378-10382	that	_
71-13	10383-10386	all	_
71-14	10387-10399	participants	_
71-15	10400-10403	did	_
71-16	10404-10406	in	_
71-17	10407-10411	fact	_
71-18	10412-10417	learn	_
71-19	10418-10421	the	_
71-20	10422-10433	shape-color	_
71-21	10434-10446	associations	_
71-22	10447-10448	.	_

72-1	10449-10451	We	_
72-2	10452-10462	calculated	_
72-3	10463-10466	the	_
72-4	10467-10477	difference	_
72-5	10478-10485	between	_
72-6	10486-10495	post-test	_
72-7	10496-10504	accuracy	_
72-8	10505-10508	and	_
72-9	10509-10517	pre-test	_
72-10	10518-10526	accuracy	_
72-11	10527-10528	,	_
72-12	10529-10532	and	_
72-13	10533-10541	excluded	_
72-14	10542-10545	any	_
72-15	10546-10556	individual	_
72-16	10557-10560	who	_
72-17	10561-10564	was	_
72-18	10565-10570	below	_
72-19	10571-10572	3	_
72-20	10573-10581	standard	_
72-21	10582-10592	deviations	_
72-22	10593-10597	from	_
72-23	10598-10601	the	_
72-24	10602-10607	group	_
72-25	10608-10612	mean	_
72-26	10613-10614	.	_

73-1	10615-10620	Using	_
73-2	10621-10625	this	_
73-3	10626-10632	method	_
73-4	10633-10634	,	_
73-5	10635-10640	three	_
73-6	10641-10643	HC	_
73-7	10644-10655	individuals	_
73-8	10656-10660	were	_
73-9	10661-10669	excluded	_
73-10	10670-10674	from	_
73-11	10675-10678	our	_
73-12	10679-10687	analyses	_
73-13	10688-10689	.	_

74-1	10690-10691	2	_
74-2	10692-10694	of	_
74-3	10695-10698	the	_
74-4	10699-10700	3	_
74-5	10701-10705	were	_
74-6	10706-10711	below	_
74-7	10712-10718	chance	_
74-8	10719-10721	in	_
74-9	10722-10727	their	_
74-10	10728-10737	post-test	_
74-11	10738-10747	responses	_
74-12	10748-10749	;	_
74-13	10750-10753	the	_
74-14	10754-10759	third	_
74-15	10760-10770	individual	_
74-16	10771-10777	showed	_
74-17	10778-10782	poor	_
74-18	10783-10792	post-test	_
74-19	10793-10801	accuracy	_
74-20	10802-10803	,	_
74-21	10804-10810	little	_
74-22	10811-10817	change	_
74-23	10818-10822	from	_
74-24	10823-10827	pre-	_
74-25	10828-10830	to	_
74-26	10831-10840	post-test	_
74-27	10841-10842	,	_
74-28	10843-10846	and	_
74-29	10847-10850	had	_
74-30	10851-10856	below	_
74-31	10857-10863	chance	_
74-32	10864-10872	accuracy	_
74-33	10873-10875	on	_
74-34	10876-10882	blocks	_
74-35	10883-10886	3–6	_
74-36	10887-10889	of	_
74-37	10890-10893	the	_
74-38	10894-10902	learning	_
74-39	10903-10907	task	_
74-40	10908-10918	suggesting	_
74-41	10919-10920	a	_
74-42	10921-10925	lack	_
74-43	10926-10928	of	_
74-44	10929-10939	compliance	_
74-45	10940-10944	with	_
74-46	10945-10949	task	_
74-47	10950-10962	instructions	_
74-48	10963-10964	.	_

75-1	10965-10970	First	_
75-2	10971-10972	,	_
75-3	10973-10975	as	_
75-4	10976-10977	a	_
75-5	10978-10990	manipulation	_
75-6	10991-10996	check	_
75-7	10997-10999	to	_
75-8	11000-11004	test	_
75-9	11005-11012	whether	_
75-10	11013-11021	learning	_
75-11	11022-11025	did	_
75-12	11026-11032	indeed	_
75-13	11033-11038	occur	_
75-14	11039-11040	,	_
75-15	11041-11043	we	_
75-16	11044-11052	compared	_
75-17	11053-11061	accuracy	_
75-18	11062-11067	under	_
75-19	11068-11077	dual-task	_
75-20	11078-11088	conditions	_
75-21	11089-11095	before	_
75-22	11096-11099	and	_
75-23	11100-11105	after	_
75-24	11106-11109	the	_
75-25	11110-11118	learning	_
75-26	11119-11127	paradigm	_
75-27	11128-11133	using	_
75-28	11134-11135	a	_
75-29	11136-11137	2	_
75-30	11138-11139	×	_
75-31	11140-11141	2	_
75-32	11142-11143	(	_
75-33	11144-11149	group	_
75-34	11150-11151	x	_
75-35	11152-11161	timepoint	_
75-36	11162-11163	)	_
75-37	11164-11169	mixed	_
75-38	11170-11175	model	_
75-39	11176-11181	ANOVA	_
75-40	11182-11183	.	_

76-1	11184-11186	To	_
76-2	11187-11198	investigate	_
76-3	11199-11207	learning	_
76-4	11208-11214	during	_
76-5	11215-11218	the	_
76-6	11219-11220	6	_
76-7	11221-11229	learning	_
76-8	11230-11236	blocks	_
76-9	11237-11247	themselves	_
76-10	11248-11249	,	_
76-11	11250-11252	we	_
76-12	11253-11257	took	_
76-13	11258-11261	two	_
76-14	11262-11272	approaches	_
76-15	11273-11274	.	_

77-1	11275-11280	First	_
77-2	11281-11282	,	_
77-3	11283-11285	we	_
77-4	11286-11290	used	_
77-5	11291-11292	a	_
77-6	11293-11294	2	_
77-7	11295-11296	×	_
77-8	11297-11298	6	_
77-9	11299-11300	(	_
77-10	11301-11306	group	_
77-11	11307-11308	x	_
77-12	11309-11314	block	_
77-13	11315-11316	)	_
77-14	11317-11322	mixed	_
77-15	11323-11328	model	_
77-16	11329-11334	ANOVA	_
77-17	11335-11337	to	_
77-18	11338-11349	investigate	_
77-19	11350-11361	performance	_
77-20	11362-11368	across	_
77-21	11369-11372	the	_
77-22	11373-11377	task	_
77-23	11378-11384	blocks	_
77-24	11385-11386	.	_

78-1	11387-11389	We	_
78-2	11390-11394	were	_
78-3	11395-11399	also	_
78-4	11400-11410	interested	_
78-5	11411-11413	in	_
78-6	11414-11427	investigating	_
78-7	11428-11431	the	_
78-8	11432-11436	rate	_
78-9	11437-11439	of	_
78-10	11440-11448	learning	_
78-11	11449-11450	,	_
78-12	11451-11462	paralleling	_
78-13	11463-11473	approaches	_
78-14	11474-11479	taken	_
78-15	11480-11482	in	_
78-16	11483-11488	motor	_
78-17	11489-11497	learning	_
78-18	11498-11507	paradigms	_
78-19	11508-11509	.	_

79-1	11510-11514	Here	_
79-2	11515-11516	,	_
79-3	11517-11519	we	_
79-4	11520-11524	were	_
79-5	11525-11535	especially	_
79-6	11536-11546	interested	_
79-7	11547-11549	in	_
79-8	11550-11553	the	_
79-9	11554-11561	initial	_
79-10	11562-11567	early	_
79-11	11568-11576	learning	_
79-12	11577-11582	phase	_
79-13	11583-11584	,	_
79-14	11585-11587	as	_
79-15	11588-11598	cerebellar	_
79-16	11599-11609	engagement	_
79-17	11610-11613	has	_
79-18	11614-11618	been	_
79-19	11619-11624	shown	_
79-20	11625-11627	to	_
79-21	11628-11634	change	_
79-22	11635-11641	during	_
79-23	11642-11645	the	_
79-24	11646-11651	early	_
79-25	11652-11658	phases	_
79-26	11659-11661	of	_
79-27	11662-11670	learning	_
79-28	11671-11672	.	_

80-1	11673-11675	To	_
80-2	11676-11685	determine	_
80-3	11686-11689	the	_
80-4	11690-11695	early	_
80-5	11696-11704	learning	_
80-6	11705-11710	phase	_
80-7	11711-11712	,	_
80-8	11713-11715	we	_
80-9	11716-11724	followed	_
80-10	11725-11728	the	_
80-11	11729-11739	procedures	_
80-12	11740-11748	outlined	_
80-13	11749-11751	by	_
80-14	11752-11759	Anguera	_
80-15	11760-11763	and	_
80-16	11764-11774	colleagues	_
80-17	11775-11776	.	_

81-1	11777-11779	We	_
81-2	11780-11789	collapsed	_
81-3	11790-11796	across	_
81-4	11797-11803	groups	_
81-5	11804-11807	and	_
81-6	11808-11818	calculated	_
81-7	11819-11822	the	_
81-8	11823-11828	slope	_
81-9	11829-11832	for	_
81-10	11833-11844	consecutive	_
81-11	11845-11851	blocks	_
81-12	11852-11854	of	_
81-13	11855-11865	increasing	_
81-14	11866-11872	length	_
81-15	11873-11874	(	_
81-16	11875-11879	e.g.	_
81-17	11880-11881	,	_
81-18	11882-11887	first	_
81-19	11888-11891	two	_
81-20	11892-11898	blocks	_
81-21	11899-11900	,	_
81-22	11901-11906	first	_
81-23	11907-11912	three	_
81-24	11913-11919	blocks	_
81-25	11920-11921	)	_
81-26	11922-11923	,	_
81-27	11924-11927	and	_
81-28	11928-11934	tested	_
81-29	11935-11940	which	_
81-30	11941-11952	combination	_
81-31	11953-11961	resulted	_
81-32	11962-11964	in	_
81-33	11965-11966	a	_
81-34	11967-11978	significant	_
81-35	11979-11983	drop	_
81-36	11984-11986	in	_
81-37	11987-11992	slope	_
81-38	11993-11994	.	_

82-1	11995-11997	We	_
82-2	11998-12005	limited	_
82-3	12006-12009	our	_
82-4	12010-12018	analyses	_
82-5	12019-12021	to	_
82-6	12022-12025	the	_
82-7	12026-12031	first	_
82-8	12032-12036	four	_
82-9	12037-12043	blocks	_
82-10	12044-12045	,	_
82-11	12046-12048	as	_
82-12	12049-12053	upon	_
82-13	12054-12060	visual	_
82-14	12061-12071	inspection	_
82-15	12072-12073	,	_
82-16	12074-12086	participants	_
82-17	12087-12089	in	_
82-18	12090-12094	both	_
82-19	12095-12101	groups	_
82-20	12102-12107	began	_
82-21	12108-12110	to	_
82-22	12111-12116	reach	_
82-23	12117-12127	asymptotic	_
82-24	12128-12139	performance	_
82-25	12140-12145	after	_
82-26	12146-12151	block	_
82-27	12152-12153	4	_
82-28	12154-12155	.	_

83-1	12156-12158	We	_
83-2	12159-12163	then	_
83-3	12164-12172	compared	_
83-4	12173-12176	the	_
83-5	12177-12182	early	_
83-6	12183-12191	learning	_
83-7	12192-12196	rate	_
83-8	12197-12204	between	_
83-9	12205-12208	the	_
83-10	12209-12212	two	_
83-11	12213-12219	groups	_
83-12	12220-12221	.	_

84-1	12222-12227	While	_
84-2	12228-12231	the	_
84-3	12232-12241	dual-task	_
84-4	12242-12251	condition	_
84-5	12252-12254	is	_
84-6	12255-12263	critical	_
84-7	12264-12267	for	_
84-8	12268-12275	testing	_
84-9	12276-12279	the	_
84-10	12280-12288	learning	_
84-11	12289-12301	manipulation	_
84-12	12302-12303	,	_
84-13	12304-12306	it	_
84-14	12307-12311	also	_
84-15	12312-12318	allows	_
84-16	12319-12321	us	_
84-17	12322-12324	to	_
84-18	12325-12336	investigate	_
84-19	12337-12340	the	_
84-20	12341-12350	dual-task	_
84-21	12351-12355	cost	_
84-22	12356-12357	,	_
84-23	12358-12363	which	_
84-24	12364-12367	can	_
84-25	12368-12375	provide	_
84-26	12376-12383	further	_
84-27	12384-12391	insight	_
84-28	12392-12396	into	_
84-29	12397-12400	the	_
84-30	12401-12407	degree	_
84-31	12408-12410	to	_
84-32	12411-12416	which	_
84-33	12417-12428	individuals	_
84-34	12429-12436	learned	_
84-35	12437-12440	and	_
84-36	12441-12452	automatized	_
84-37	12453-12454	a	_
84-38	12455-12459	task	_
84-39	12460-12461	.	_

85-1	12462-12466	Thus	_
85-2	12467-12468	,	_
85-3	12469-12471	we	_
85-4	12472-12484	investigated	_
85-5	12485-12490	group	_
85-6	12491-12502	differences	_
85-7	12503-12505	in	_
85-8	12506-12509	the	_
85-9	12510-12519	dual-task	_
85-10	12520-12524	cost	_
85-11	12525-12532	between	_
85-12	12533-12536	the	_
85-13	12537-12540	CHR	_
85-14	12541-12544	and	_
85-15	12545-12552	control	_
85-16	12553-12559	groups	_
85-17	12560-12565	after	_
85-18	12566-12574	learning	_
85-19	12575-12576	.	_

86-1	12577-12586	Dual-task	_
86-2	12587-12591	cost	_
86-3	12592-12595	was	_
86-4	12596-12611	operationalized	_
86-5	12612-12614	as	_
86-6	12615-12618	the	_
86-7	12619-12629	difference	_
86-8	12630-12632	in	_
86-9	12633-12641	accuracy	_
86-10	12642-12649	between	_
86-11	12650-12653	the	_
86-12	12654-12658	last	_
86-13	12659-12664	block	_
86-14	12665-12667	of	_
86-15	12668-12671	the	_
86-16	12672-12680	learning	_
86-17	12681-12685	task	_
86-18	12686-12689	and	_
86-19	12690-12693	the	_
86-20	12694-12703	dual-task	_
86-21	12704-12713	condition	_
86-22	12714-12718	that	_
86-23	12719-12730	immediately	_
86-24	12731-12739	followed	_
86-25	12740-12741	(	_
86-26	12742-12747	block	_
86-27	12748-12749	6	_
86-28	12750-12758	accuracy	_
86-29	12759-12760	–	_
86-30	12761-12770	dual-task	_
86-31	12771-12779	accuracy	_
86-32	12780-12781	)	_
86-33	12782-12783	.	_

87-1	12784-12792	Positive	_
87-2	12793-12799	values	_
87-3	12800-12808	indicate	_
87-4	12809-12815	better	_
87-5	12816-12827	performance	_
87-6	12828-12833	under	_
87-7	12834-12837	the	_
87-8	12838-12844	single	_
87-9	12845-12849	task	_
87-10	12850-12860	conditions	_
87-11	12861-12862	,	_
87-12	12863-12866	and	_
87-13	12867-12870	the	_
87-14	12871-12877	higher	_
87-15	12878-12881	the	_
87-16	12882-12887	value	_
87-17	12888-12889	,	_
87-18	12890-12893	the	_
87-19	12894-12901	greater	_
87-20	12902-12906	cost	_
87-21	12907-12909	of	_
87-22	12910-12920	performing	_
87-23	12921-12926	under	_
87-24	12927-12936	dual-task	_
87-25	12937-12947	conditions	_
87-26	12948-12949	.	_

88-1	12950-12957	Finally	_
88-2	12958-12959	,	_
88-3	12960-12962	as	_
88-4	12963-12965	we	_
88-5	12966-12970	were	_
88-6	12971-12981	interested	_
88-7	12982-12984	in	_
88-8	12985-12992	whether	_
88-9	12993-12995	or	_
88-10	12996-12999	not	_
88-11	13000-13009	non-motor	_
88-12	13010-13018	learning	_
88-13	13019-13021	is	_
88-14	13022-13029	related	_
88-15	13030-13032	to	_
88-16	13033-13040	symptom	_
88-17	13041-13049	severity	_
88-18	13050-13052	in	_
88-19	13053-13056	CHR	_
88-20	13057-13068	individuals	_
88-21	13069-13070	,	_
88-22	13071-13073	we	_
88-23	13074-13078	also	_
88-24	13079-13091	investigated	_
88-25	13092-13104	correlations	_
88-26	13105-13112	between	_
88-27	13113-13118	early	_
88-28	13119-13127	learning	_
88-29	13128-13133	slope	_
88-30	13134-13135	,	_
88-31	13136-13139	and	_
88-32	13140-13148	severity	_
88-33	13149-13151	of	_
88-34	13152-13160	positive	_
88-35	13161-13162	,	_
88-36	13163-13171	negative	_
88-37	13172-13173	,	_
88-38	13174-13177	and	_
88-39	13178-13190	disorganized	_
88-40	13191-13199	symptoms	_
88-41	13200-13202	in	_
88-42	13203-13206	the	_
88-43	13207-13210	CHR	_
88-44	13211-13216	group	_
88-45	13217-13218	.	_

89-1	13219-13223	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
89-2	13224-13228	data	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
89-3	13229-13240	acquisition	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
89-4	13241-13244	All	_
89-5	13245-13255	functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
89-6	13256-13263	imaging	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
89-7	13264-13268	data	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
89-8	13269-13272	was	_
89-9	13273-13282	collected	_
89-10	13283-13288	using	_
89-11	13289-13290	a	_
89-12	13291-13292	3	_
89-13	13293-13294	T	_
89-14	13295-13302	Siemens	_
89-15	13303-13311	Magnetom	_
89-16	13312-13315	Tim	_
89-17	13316-13320	Trio	_
89-18	13321-13322	(	_
89-19	13323-13331	software	_
89-20	13332-13339	version	_
89-21	13340-13345	VB17A	_
89-22	13346-13347	;	_
89-23	13348-13354	Munich	_
89-24	13355-13356	,	_
89-25	13357-13364	Germany	_
89-26	13365-13366	)	_
89-27	13367-13368	,	_
89-28	13369-13374	using	_
89-29	13375-13385	multi-band	_
89-30	13386-13396	functional	_
89-31	13397-13402	pulse	_
89-32	13403-13412	sequences	_
89-33	13413-13417	with	_
89-34	13418-13419	a	_
89-35	13420-13430	32-channel	_
89-36	13431-13435	head	_
89-37	13436-13440	coil	_
89-38	13441-13442	.	_

90-1	13443-13452	Sequences	_
90-2	13453-13456	for	_
90-3	13457-13467	multi-band	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
90-4	13468-13478	functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
90-5	13479-13486	imaging	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
90-6	13487-13491	were	_
90-7	13492-13500	acquired	_
90-8	13501-13505	from	_
90-9	13506-13509	the	_
90-10	13510-13516	Center	_
90-11	13517-13520	for	_
90-12	13521-13529	Magnetic	_
90-13	13530-13539	Resonance	_
90-14	13540-13548	Research	_
90-15	13549-13550	(	_
90-16	13551-13555	http	_
90-17	13556-13557	:	_
90-18	13558-13598	//www.cmrr.umn.edu/multiband/index.shtml	_
90-19	13599-13600	)	_
90-20	13601-13604	and	_
90-21	13605-13613	modified	_
90-22	13614-13616	as	_
90-23	13617-13623	needed	_
90-24	13624-13627	for	_
90-25	13628-13631	the	_
90-26	13632-13635	UCB	_
90-27	13636-13643	scanner	_
90-28	13644-13645	.	_

91-1	13646-13649	The	_
91-2	13650-13660	multi-band	_
91-3	13661-13666	pulse	_
91-4	13667-13676	sequences	_
91-5	13677-13682	allow	_
91-6	13683-13686	for	_
91-7	13687-13693	faster	_
91-8	13694-13698	data	_
91-9	13699-13710	acquisition	_
91-10	13711-13712	,	_
91-11	13713-13720	wherein	_
91-12	13721-13723	we	_
91-13	13724-13728	were	_
91-14	13729-13733	able	_
91-15	13734-13736	to	_
91-16	13737-13745	decrease	_
91-17	13746-13749	the	_
91-18	13750-13752	TR	_
91-19	13753-13758	while	_
91-20	13759-13764	still	_
91-21	13765-13776	maintaining	_
91-22	13777-13780	the	_
91-23	13781-13791	full-brain	_
91-24	13792-13800	coverage	_
91-25	13801-13809	required	_
91-26	13810-13812	to	_
91-27	13813-13824	investigate	_
91-28	13825-13828	the	_
91-29	13829-13839	cerebellum	_
91-30	13840-13841	.	_

92-1	13842-13853	Furthermore	_
92-2	13854-13855	,	_
92-3	13856-13861	these	_
92-4	13862-13871	sequences	_
92-5	13872-13881	eliminate	_
92-6	13882-13885	the	_
92-7	13886-13890	need	_
92-8	13891-13894	for	_
92-9	13895-13900	slice	_
92-10	13901-13907	timing	_
92-11	13908-13918	correction	_
92-12	13919-13920	,	_
92-13	13921-13924	and	_
92-14	13925-13934	increases	_
92-15	13935-13944	buffering	_
92-16	13945-13952	against	_
92-17	13953-13959	motion	_
92-18	13960-13969	artifacts	_
92-19	13970-13972	as	_
92-20	13973-13981	multiple	_
92-21	13982-13988	slices	_
92-22	13989-13992	are	_
92-23	13993-14002	collected	_
92-24	14003-14005	in	_
92-25	14006-14009	the	_
92-26	14010-14014	same	_
92-27	14015-14019	time	_
92-28	14020-14022	it	_
92-29	14023-14028	takes	_
92-30	14029-14040	traditional	_
92-31	14041-14048	imaging	_
92-32	14049-14058	sequences	_
92-33	14059-14061	to	_
92-34	14062-14069	collect	_
92-35	14070-14073	one	_
92-36	14074-14075	.	_

93-1	14076-14079	The	_
93-2	14080-14086	latter	_
93-3	14087-14093	motion	_
93-4	14094-14100	factor	_
93-5	14101-14103	is	_
93-6	14104-14116	particularly	_
93-7	14117-14123	useful	_
93-8	14124-14128	when	_
93-9	14129-14136	working	_
93-10	14137-14141	with	_
93-11	14142-14152	adolescent	_
93-12	14153-14156	and	_
93-13	14157-14165	clinical	_
93-14	14166-14177	populations	_
93-15	14178-14183	where	_
93-16	14184-14196	participants	_
93-17	14197-14200	may	_
93-18	14201-14203	be	_
93-19	14204-14208	more	_
93-20	14209-14215	likely	_
93-21	14216-14218	to	_
93-22	14219-14223	move	_
93-23	14224-14226	in	_
93-24	14227-14230	the	_
93-25	14231-14238	scanner	_
93-26	14239-14240	.	_

94-1	14241-14251	Structural	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
94-2	14252-14258	images	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
94-3	14259-14263	were	_
94-4	14264-14272	acquired	_
94-5	14273-14278	using	_
94-6	14279-14280	a	_
94-7	14281-14289	sagittal	http://maven.renci.org/NeuroBridge/neurobridge#DigitalScale
94-8	14290-14301	T1-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
94-9	14302-14313	interleaved	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
94-10	14314-14322	sequence	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
94-11	14323-14324	(	_
94-12	14325-14335	repetition	_
94-13	14336-14340	time	_
94-14	14341-14342	(	_
94-15	14343-14345	TR	_
94-16	14346-14347	)	_
94-17	14348-14349	=	_
94-18	14350-14354	2400	_
94-19	14355-14357	ms	_
94-20	14358-14359	,	_
94-21	14360-14369	echo-time	_
94-22	14370-14371	(	_
94-23	14372-14374	TE	_
94-24	14375-14376	)	_
94-25	14377-14378	=	_
94-26	14379-14383	2.01	_
94-27	14384-14386	ms	_
94-28	14387-14388	,	_
94-29	14389-14393	echo	_
94-30	14394-14401	spacing	_
94-31	14402-14403	=	_
94-32	14404-14407	7.4	_
94-33	14408-14410	ms	_
94-34	14411-14412	,	_
94-35	14413-14417	flip	_
94-36	14418-14423	angle	_
94-37	14424-14425	=	_
94-38	14426-14428	8°	_
94-39	14429-14430	,	_
94-40	14431-14444	field-of-view	_
94-41	14445-14446	=	_
94-42	14447-14450	256	_
94-43	14451-14453	mm	_
94-44	14454-14455	×	_
94-45	14456-14459	256	_
94-46	14460-14462	mm	_
94-47	14463-14464	×	_
94-48	14465-14468	180	_
94-49	14469-14471	mm	_
94-50	14472-14473	,	_
94-51	14474-14479	voxel	_
94-52	14480-14490	resolution	_
94-53	14491-14492	=	_
94-54	14493-14496	0.8	_
94-55	14497-14499	mm	_
94-56	14500-14509	isotropic	_
94-57	14510-14511	)	_
94-58	14512-14513	.	_

95-1	14514-14517	Six	_
95-2	14518-14522	runs	_
95-3	14523-14525	of	_
95-4	14526-14535	multiband	_
95-5	14536-14540	EPIs	_
95-6	14541-14542	,	_
95-7	14543-14556	corresponding	_
95-8	14557-14559	to	_
95-9	14560-14563	our	_
95-10	14564-14565	6	_
95-11	14566-14570	task	_
95-12	14571-14577	blocks	_
95-13	14578-14579	(	_
95-14	14580-14589	described	_
95-15	14590-14595	above	_
95-16	14596-14597	)	_
95-17	14598-14599	,	_
95-18	14600-14604	were	_
95-19	14605-14613	acquired	_
95-20	14614-14616	in	_
95-21	14617-14620	the	_
95-22	14621-14630	posterior	_
95-23	14631-14633	to	_
95-24	14634-14642	anterior	_
95-25	14643-14652	direction	_
95-26	14653-14657	with	_
95-27	14658-14661	the	_
95-28	14662-14671	following	_
95-29	14672-14682	parameters	_
95-30	14683-14684	(	_
95-31	14685-14694	multiband	_
95-32	14695-14707	acceleration	_
95-33	14708-14714	factor	_
95-34	14715-14716	=	_
95-35	14717-14718	8	_
95-36	14719-14720	,	_
95-37	14721-14730	bandwidth	_
95-38	14731-14732	=	_
95-39	14733-14737	2772	_
95-40	14738-14743	Hz/Px	_
95-41	14744-14745	,	_
95-42	14746-14748	TR	_
95-43	14749-14750	=	_
95-44	14751-14754	460	_
95-45	14755-14757	ms	_
95-46	14758-14759	,	_
95-47	14760-14762	TE	_
95-48	14763-14764	=	_
95-49	14765-14769	29.0	_
95-50	14770-14771	,	_
95-51	14772-14784	echo-spacing	_
95-52	14785-14786	=	_
95-53	14787-14791	0.51	_
95-54	14792-14794	ms	_
95-55	14795-14796	,	_
95-56	14797-14807	flip-angle	_
95-57	14808-14809	=	_
95-58	14810-14813	44°	_
95-59	14814-14815	,	_
95-60	14816-14829	field-of-view	_
95-61	14830-14831	=	_
95-62	14832-14835	248	_
95-63	14836-14837	×	_
95-64	14838-14841	248	_
95-65	14842-14843	×	_
95-66	14844-14847	168	_
95-67	14848-14850	mm	_
95-68	14851-14852	,	_
95-69	14853-14858	voxel	_
95-70	14859-14869	resolution	_
95-71	14870-14871	=	_
95-72	14872-14875	3.0	_
95-73	14876-14878	mm	_
95-74	14879-14888	isotropic	_
95-75	14889-14890	,	_
95-76	14891-14897	number	_
95-77	14898-14900	of	_
95-78	14901-14907	slices	_
95-79	14908-14909	=	_
95-80	14910-14912	56	_
95-81	14913-14914	,	_
95-82	14915-14919	time	_
95-83	14920-14921	=	_
95-84	14922-14926	4:00	_
95-85	14927-14930	min	_
95-86	14931-14932	)	_
95-87	14933-14934	.	_

96-1	14935-14937	We	_
96-2	14938-14942	also	_
96-3	14943-14952	collected	_
96-4	14953-14956	two	_
96-5	14957-14962	brief	_
96-6	14963-14964	(	_
96-7	14965-14967	20	_
96-8	14968-14975	volumes	_
96-9	14976-14980	each	_
96-10	14981-14982	)	_
96-11	14983-14988	scans	_
96-12	14989-14994	prior	_
96-13	14995-14997	to	_
96-14	14998-15001	the	_
96-15	15002-15012	functional	_
96-16	15013-15020	imaging	_
96-17	15021-15025	runs	_
96-18	15026-15027	,	_
96-19	15028-15033	using	_
96-20	15034-15037	the	_
96-21	15038-15042	same	_
96-22	15043-15046	EPI	_
96-23	15047-15057	parameters	_
96-24	15058-15061	but	_
96-25	15062-15071	collected	_
96-26	15072-15074	in	_
96-27	15075-15079	both	_
96-28	15080-15083	the	_
96-29	15084-15105	anterior-to-posterior	_
96-30	15106-15109	and	_
96-31	15110-15131	posterior-to-anterior	_
96-32	15132-15142	directions	_
96-33	15143-15144	.	_

97-1	15145-15150	These	_
97-2	15151-15156	scans	_
97-3	15157-15165	acquired	_
97-4	15166-15168	in	_
97-5	15169-15174	order	_
97-6	15175-15177	to	_
97-7	15178-15186	estimate	_
97-8	15187-15190	and	_
97-9	15191-15198	correct	_
97-10	15199-15202	for	_
97-11	15203-15213	distortion	_
97-12	15214-15215	.	_

98-1	15216-15219	The	_
98-2	15220-15221	6	_
98-3	15222-15226	runs	_
98-4	15227-15229	of	_
98-5	15230-15240	functional	_
98-6	15241-15245	data	_
98-7	15246-15250	were	_
98-8	15251-15260	collected	_
98-9	15261-15266	while	_
98-10	15267-15278	individuals	_
98-11	15279-15283	were	_
98-12	15284-15294	performing	_
98-13	15295-15298	the	_
98-14	15299-15311	second-order	_
98-15	15312-15320	learning	_
98-16	15321-15325	task	_
98-17	15326-15327	.	_

99-1	15328-15332	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
99-2	15333-15337	data	_
99-3	15338-15352	pre-processing	_
99-4	15353-15356	and	_
99-5	15357-15365	analysis	_
99-6	15366-15368	As	_
99-7	15369-15374	noted	_
99-8	15375-15380	above	_
99-9	15381-15382	,	_
99-10	15383-15384	3	_
99-11	15385-15387	HC	_
99-12	15388-15399	individuals	_
99-13	15400-15404	were	_
99-14	15405-15413	excluded	_
99-15	15414-15418	from	_
99-16	15419-15422	our	_
99-17	15423-15433	subsequent	_
99-18	15434-15442	analyses	_
99-19	15443-15446	due	_
99-20	15447-15449	to	_
99-21	15450-15454	poor	_
99-22	15455-15466	performance	_
99-23	15467-15470	and	_
99-24	15471-15472	a	_
99-25	15473-15485	demonstrable	_
99-26	15486-15490	lack	_
99-27	15491-15493	of	_
99-28	15494-15502	learning	_
99-29	15503-15509	during	_
99-30	15510-15513	the	_
99-31	15514-15522	learning	_
99-32	15523-15531	paradigm	_
99-33	15532-15533	.	_

100-1	15534-15536	As	_
100-2	15537-15541	such	_
100-3	15542-15543	,	_
100-4	15544-15547	our	_
100-5	15548-15553	final	_
100-6	15554-15560	sample	_
100-7	15561-15564	for	_
100-8	15565-15573	analysis	_
100-9	15574-15582	included	_
100-10	15583-15585	18	_
100-11	15586-15588	HC	_
100-12	15589-15600	individuals	_
100-13	15601-15602	,	_
100-14	15603-15606	and	_
100-15	15607-15609	20	_
100-16	15610-15613	CHR	_
100-17	15614-15615	.	_

101-1	15616-15619	The	_
101-2	15620-15625	first	_
101-3	15626-15627	6	_
101-4	15628-15635	volumes	_
101-5	15636-15638	of	_
101-6	15639-15643	each	_
101-7	15644-15654	functional	_
101-8	15655-15658	run	_
101-9	15659-15663	were	_
101-10	15664-15671	removed	_
101-11	15672-15674	to	_
101-12	15675-15680	allow	_
101-13	15681-15684	for	_
101-14	15685-15692	scanner	_
101-15	15693-15704	equilibrium	_
101-16	15705-15706	,	_
101-17	15707-15710	and	_
101-18	15711-15721	functional	_
101-19	15722-15726	data	_
101-20	15727-15730	was	_
101-21	15731-15740	corrected	_
101-22	15741-15744	for	_
101-23	15745-15756	distortions	_
101-24	15757-15762	using	_
101-25	15763-15766	FSL	_
101-26	15767-15769	's	_
101-27	15770-15775	topup	_
101-28	15776-15777	.	_

102-1	15778-15788	Additional	_
102-2	15789-15793	FMRI	_
102-3	15794-15798	data	_
102-4	15799-15812	preprocessing	_
102-5	15813-15816	was	_
102-6	15817-15824	carried	_
102-7	15825-15828	out	_
102-8	15829-15834	using	_
102-9	15835-15839	FEAT	_
102-10	15840-15841	(	_
102-11	15842-15846	FMRI	_
102-12	15847-15853	Expert	_
102-13	15854-15862	Analysis	_
102-14	15863-15867	Tool	_
102-15	15868-15869	)	_
102-16	15870-15877	Version	_
102-17	15878-15882	6.00	_
102-18	15883-15884	,	_
102-19	15885-15889	part	_
102-20	15890-15892	of	_
102-21	15893-15896	FSL	_
102-22	15897-15898	(	_
102-23	15899-15904	FMRIB	_
102-24	15905-15907	's	_
102-25	15908-15916	Software	_
102-26	15917-15924	Library	_
102-27	15925-15926	,	_
102-28	15927-15949	www.fmrib.ox.ac.uk/fsl	_
102-29	15950-15951	)	_
102-30	15952-15953	.	_

103-1	15954-15957	The	_
103-2	15958-15967	following	_
103-3	15968-15982	pre-statistics	_
103-4	15983-15993	processing	_
103-5	15994-15997	was	_
103-6	15998-16005	applied	_
103-7	16006-16007	:	_
103-8	16008-16014	motion	_
103-9	16015-16025	correction	_
103-10	16026-16031	using	_
103-11	16032-16039	MCFLIRT	_
103-12	16040-16041	;	_
103-13	16042-16051	non-brain	_
103-14	16052-16059	removal	_
103-15	16060-16065	using	_
103-16	16066-16069	BET	_
103-17	16070-16071	;	_
103-18	16072-16079	spatial	_
103-19	16080-16089	smoothing	_
103-20	16090-16095	using	_
103-21	16096-16097	a	_
103-22	16098-16106	Gaussian	_
103-23	16107-16113	kernel	_
103-24	16114-16116	of	_
103-25	16117-16121	FWHM	_
103-26	16122-16123	6	_
103-27	16124-16126	mm	_
103-28	16127-16128	;	_
103-29	16129-16132	and	_
103-30	16133-16143	grand-mean	_
103-31	16144-16153	intensity	_
103-32	16154-16167	normalization	_
103-33	16168-16170	of	_
103-34	16171-16174	the	_
103-35	16175-16181	entire	_
103-36	16182-16184	4D	_
103-37	16185-16192	dataset	_
103-38	16193-16195	by	_
103-39	16196-16197	a	_
103-40	16198-16204	single	_
103-41	16205-16219	multiplicative	_
103-42	16220-16226	factor	_
103-43	16227-16228	.	_

104-1	16229-16235	Motion	_
104-2	16236-16245	artifacts	_
104-3	16246-16250	were	_
104-4	16251-16255	then	_
104-5	16256-16263	removed	_
104-6	16264-16269	using	_
104-7	16270-16279	automated	_
104-8	16280-16289	ICA-based	_
104-9	16290-16297	methods	_
104-10	16298-16299	.	_

105-1	16300-16312	Registration	_
105-2	16313-16315	to	_
105-3	16316-16320	high	_
105-4	16321-16331	resolution	_
105-5	16332-16342	structural	_
105-6	16343-16349	and/or	_
105-7	16350-16358	standard	_
105-8	16359-16364	space	_
105-9	16365-16371	images	_
105-10	16372-16375	was	_
105-11	16376-16383	carried	_
105-12	16384-16387	out	_
105-13	16388-16393	using	_
105-14	16394-16399	FLIRT	_
105-15	16400-16404	with	_
105-16	16405-16408	the	_
105-17	16409-16417	Boundary	_
105-18	16418-16423	Based	_
105-19	16424-16436	Registration	_
105-20	16437-16438	(	_
105-21	16439-16442	BBR	_
105-22	16443-16444	)	_
105-23	16445-16449	cost	_
105-24	16450-16458	function	_
105-25	16459-16460	.	_

106-1	16461-16473	Registration	_
106-2	16474-16478	from	_
106-3	16479-16483	high	_
106-4	16484-16494	resolution	_
106-5	16495-16505	structural	_
106-6	16506-16508	to	_
106-7	16509-16517	standard	_
106-8	16518-16523	space	_
106-9	16524-16527	was	_
106-10	16528-16532	then	_
106-11	16533-16540	further	_
106-12	16541-16548	refined	_
106-13	16549-16554	using	_
106-14	16555-16560	FNIRT	_
106-15	16561-16570	nonlinear	_
106-16	16571-16583	registration	_
106-17	16584-16585	.	_

107-1	16586-16598	Registration	_
107-2	16599-16601	as	_
107-3	16602-16611	completed	_
107-4	16612-16616	with	_
107-5	16617-16620	FSL	_
107-6	16621-16625	does	_
107-7	16626-16627	a	_
107-8	16628-16640	particularly	_
107-9	16641-16645	good	_
107-10	16646-16649	job	_
107-11	16650-16652	of	_
107-12	16653-16664	normalizing	_
107-13	16665-16668	the	_
107-14	16669-16679	cerebellum	_
107-15	16680-16681	,	_
107-16	16682-16685	and	_
107-17	16686-16693	because	_
107-18	16694-16696	we	_
107-19	16697-16701	were	_
107-20	16702-16714	particularly	_
107-21	16715-16725	interested	_
107-22	16726-16728	in	_
107-23	16729-16733	both	_
107-24	16734-16744	cerebellar	_
107-25	16745-16746	,	_
107-26	16747-16749	as	_
107-27	16750-16754	well	_
107-28	16755-16757	as	_
107-29	16758-16769	whole-brain	_
107-30	16770-16780	activation	_
107-31	16781-16789	patterns	_
107-32	16790-16791	,	_
107-33	16792-16794	we	_
107-34	16795-16799	used	_
107-35	16800-16801	a	_
107-36	16802-16813	whole-brain	_
107-37	16814-16822	analysis	_
107-38	16823-16831	approach	_
107-39	16832-16833	.	_

108-1	16834-16845	First-level	_
108-2	16846-16857	time-series	_
108-3	16858-16869	statistical	_
108-4	16870-16878	analysis	_
108-5	16879-16882	was	_
108-6	16883-16890	carried	_
108-7	16891-16894	out	_
108-8	16895-16900	using	_
108-9	16901-16905	FILM	_
108-10	16906-16907	(	_
108-11	16908-16913	FMRIB	_
108-12	16914-16916	's	_
108-13	16917-16925	Improved	_
108-14	16926-16932	Linear	_
108-15	16933-16938	Model	_
108-16	16939-16940	)	_
108-17	16941-16945	with	_
108-18	16946-16951	local	_
108-19	16952-16967	autocorrelation	_
108-20	16968-16978	correction	_
108-21	16979-16980	.	_

109-1	16981-16985	Data	_
109-2	16986-16990	were	_
109-3	16991-16999	highpass	_
109-4	17000-17008	temporal	_
109-5	17009-17017	filtered	_
109-6	17018-17019	(	_
109-7	17020-17037	Gaussian-weighted	_
109-8	17038-17051	least-squares	_
109-9	17052-17060	straight	_
109-10	17061-17065	line	_
109-11	17066-17073	fitting	_
109-12	17074-17075	,	_
109-13	17076-17080	with	_
109-14	17081-17086	sigma	_
109-15	17087-17088	=	_
109-16	17089-17093	45.0	_
109-17	17094-17095	s	_
109-18	17096-17097	)	_
109-19	17098-17099	.	_

110-1	17100-17103	The	_
110-2	17104-17108	BOLD	_
110-3	17109-17117	response	_
110-4	17118-17121	was	_
110-5	17122-17129	modeled	_
110-6	17130-17133	for	_
110-7	17134-17141	correct	_
110-8	17142-17146	task	_
110-9	17147-17155	response	_
110-10	17156-17159	and	_
110-11	17160-17169	incorrect	_
110-12	17170-17174	task	_
110-13	17175-17184	responses	_
110-14	17185-17186	,	_
110-15	17187-17192	using	_
110-16	17193-17194	a	_
110-17	17195-17201	double	_
110-18	17202-17207	gamma	_
110-19	17208-17219	hemodynamic	_
110-20	17220-17228	response	_
110-21	17229-17237	function	_
110-22	17238-17239	(	_
110-23	17240-17243	HRF	_
110-24	17244-17245	)	_
110-25	17246-17257	convolution	_
110-26	17258-17260	as	_
110-27	17261-17265	well	_
110-28	17266-17268	as	_
110-29	17269-17272	the	_
110-30	17273-17281	temporal	_
110-31	17282-17292	derivative	_
110-32	17293-17295	to	_
110-33	17296-17303	account	_
110-34	17304-17307	for	_
110-35	17308-17320	fluctuations	_
110-36	17321-17323	in	_
110-37	17324-17327	the	_
110-38	17328-17334	timing	_
110-39	17335-17337	of	_
110-40	17338-17341	the	_
110-41	17342-17345	HRF	_
110-42	17346-17354	waveform	_
110-43	17355-17356	.	_

111-1	17357-17361	Here	_
111-2	17362-17363	,	_
111-3	17364-17369	given	_
111-4	17370-17373	our	_
111-5	17374-17379	focus	_
111-6	17380-17382	on	_
111-7	17383-17393	activation	_
111-8	17394-17401	related	_
111-9	17402-17404	to	_
111-10	17405-17408	the	_
111-11	17409-17421	second-order	_
111-12	17422-17426	rule	_
111-13	17427-17428	,	_
111-14	17429-17432	our	_
111-15	17433-17439	events	_
111-16	17440-17444	were	_
111-17	17445-17452	defined	_
111-18	17453-17455	by	_
111-19	17456-17459	the	_
111-20	17460-17461	“	_
111-21	17462-17473	instruction	_
111-22	17474-17477	cue	_
111-23	17478-17479	”	_
111-24	17480-17482	as	_
111-25	17483-17487	this	_
111-26	17488-17491	was	_
111-27	17492-17502	temporally	_
111-28	17503-17511	distinct	_
111-29	17512-17515	and	_
111-30	17516-17527	dissociable	_
111-31	17528-17532	from	_
111-32	17533-17536	the	_
111-33	17537-17545	response	_
111-34	17546-17552	period	_
111-35	17553-17554	,	_
111-36	17555-17558	and	_
111-37	17559-17561	no	_
111-38	17562-17567	motor	_
111-39	17568-17577	responses	_
111-40	17578-17582	were	_
111-41	17583-17588	being	_
111-42	17589-17593	made	_
111-43	17594-17596	at	_
111-44	17597-17601	this	_
111-45	17602-17606	time	_
111-46	17607-17608	.	_

112-1	17609-17611	We	_
112-2	17612-17623	time-locked	_
112-3	17624-17626	to	_
112-4	17627-17630	the	_
112-5	17631-17636	onset	_
112-6	17637-17639	of	_
112-7	17640-17643	the	_
112-8	17644-17655	instruction	_
112-9	17656-17659	cue	_
112-10	17660-17672	presentation	_
112-11	17673-17675	to	_
112-12	17676-17679	the	_
112-13	17680-17691	participant	_
112-14	17692-17693	.	_

113-1	17694-17701	Summary	_
113-2	17702-17712	statistics	_
113-3	17713-17717	were	_
113-4	17718-17725	carried	_
113-5	17726-17729	out	_
113-6	17730-17732	in	_
113-7	17733-17743	two-stages	_
113-8	17744-17745	.	_

114-1	17746-17747	A	_
114-2	17748-17753	fixed	_
114-3	17754-17760	effect	_
114-4	17761-17766	model	_
114-5	17767-17770	was	_
114-6	17771-17778	defined	_
114-7	17779-17781	to	_
114-8	17782-17788	define	_
114-9	17789-17798	contrasts	_
114-10	17799-17802	for	_
114-11	17803-17808	early	_
114-12	17809-17812	and	_
114-13	17813-17817	late	_
114-14	17818-17826	learning	_
114-15	17827-17828	.	_

115-1	17829-17834	Early	_
115-2	17835-17843	learning	_
115-3	17844-17847	was	_
115-4	17848-17855	defined	_
115-5	17856-17858	as	_
115-6	17859-17862	the	_
115-7	17863-17867	mean	_
115-8	17868-17876	response	_
115-9	17877-17879	in	_
115-10	17880-17883	the	_
115-11	17884-17889	first	_
115-12	17890-17893	two	_
115-13	17894-17900	blocks	_
115-14	17901-17904	and	_
115-15	17905-17909	late	_
115-16	17910-17918	learning	_
115-17	17919-17922	was	_
115-18	17923-17930	defined	_
115-19	17931-17933	as	_
115-20	17934-17937	the	_
115-21	17938-17942	mean	_
115-22	17943-17951	response	_
115-23	17952-17954	in	_
115-24	17955-17958	the	_
115-25	17959-17963	last	_
115-26	17964-17967	two	_
115-27	17968-17974	blocks	_
115-28	17975-17976	.	_

116-1	17977-17986	Contrasts	_
116-2	17987-17991	were	_
116-3	17992-17999	defined	_
116-4	18000-18003	for	_
116-5	18004-18007	the	_
116-6	18008-18012	mean	_
116-7	18013-18015	of	_
116-8	18016-18021	early	_
116-9	18022-18025	and	_
116-10	18026-18030	late	_
116-11	18031-18039	learning	_
116-12	18040-18041	,	_
116-13	18042-18044	as	_
116-14	18045-18049	well	_
116-15	18050-18052	as	_
116-16	18053-18056	the	_
116-17	18057-18067	difference	_
116-18	18068-18075	between	_
116-19	18076-18081	early	_
116-20	18082-18085	and	_
116-21	18086-18090	late	_
116-22	18091-18099	learning	_
116-23	18100-18101	.	_

117-1	18102-18104	We	_
117-2	18105-18112	limited	_
117-3	18113-18116	our	_
117-4	18117-18125	analyses	_
117-5	18126-18128	to	_
117-6	18129-18132	the	_
117-7	18133-18137	data	_
117-8	18138-18142	from	_
117-9	18143-18150	correct	_
117-10	18151-18157	trials	_
117-11	18158-18162	only	_
117-12	18163-18164	,	_
117-13	18165-18168	for	_
117-14	18169-18172	all	_
117-15	18173-18175	of	_
117-16	18176-18179	our	_
117-17	18180-18189	contrasts	_
117-18	18190-18191	.	_

118-1	18192-18197	Group	_
118-2	18198-18203	means	_
118-3	18204-18207	and	_
118-4	18208-18213	group	_
118-5	18214-18225	differences	_
118-6	18226-18229	for	_
118-7	18230-18235	early	_
118-8	18236-18239	and	_
118-9	18240-18244	late	_
118-10	18245-18253	learning	_
118-11	18254-18258	were	_
118-12	18259-18269	calculated	_
118-13	18270-18275	using	_
118-14	18276-18277	a	_
118-15	18278-18283	mixed	_
118-16	18284-18289	model	_
118-17	18290-18295	using	_
118-18	18296-18301	FLAME	_
118-19	18302-18303	(	_
118-20	18304-18309	FMRIB	_
118-21	18310-18312	's	_
118-22	18313-18318	Local	_
118-23	18319-18327	Analysis	_
118-24	18328-18330	of	_
118-25	18331-18336	Mixed	_
118-26	18337-18344	Effects	_
118-27	18345-18346	)	_
118-28	18347-18348	.	_

119-1	18349-18354	Final	_
119-2	18355-18366	group-level	_
119-3	18367-18368	Z	_
119-4	18369-18370	(	_
119-5	18371-18383	Gaussianised	_
119-6	18384-18387	T/F	_
119-7	18388-18389	)	_
119-8	18390-18399	statistic	_
119-9	18400-18406	images	_
119-10	18407-18411	were	_
119-11	18412-18423	thresholded	_
119-12	18424-18442	non-parametrically	_
119-13	18443-18448	using	_
119-14	18449-18457	clusters	_
119-15	18458-18468	determined	_
119-16	18469-18471	by	_
119-17	18472-18473	Z	_
119-18	18474-18475	>	_
119-19	18476-18479	3.1	_
119-20	18480-18483	and	_
119-21	18484-18485	a	_
119-22	18486-18493	cluster	_
119-23	18494-18506	significance	_
119-24	18507-18516	threshold	_
119-25	18517-18519	of	_
119-26	18520-18524	pFWE	_
119-27	18525-18526	<	_
119-28	18527-18531	0.05	_
119-29	18532-18537	using	_
119-30	18538-18549	permutation	_
119-31	18550-18557	methods	_
119-32	18558-18562	with	_
119-33	18563-18567	5000	_
119-34	18568-18580	permutations	_
119-35	18581-18582	.	_

120-1	18583-18586	3-D	_
120-2	18587-18597	statistics	_
120-3	18598-18602	maps	_
120-4	18603-18607	were	_
120-5	18608-18617	projected	_
120-6	18618-18620	to	_
120-7	18621-18624	the	_
120-8	18625-18637	midthickness	_
120-9	18638-18645	surface	_
120-10	18646-18647	(	_
120-11	18648-18657	generated	_
120-12	18658-18660	by	_
120-13	18661-18670	averaging	_
120-14	18671-18674	the	_
120-15	18675-18680	white	_
120-16	18681-18684	and	_
120-17	18685-18689	pial	_
120-18	18690-18697	surface	_
120-19	18698-18709	coordinates	_
120-20	18710-18711	)	_
120-21	18712-18714	of	_
120-22	18715-18718	the	_
120-23	18719-18724	Human	_
120-24	18725-18735	Connectome	_
120-25	18736-18743	Project	_
120-26	18744-18747	900	_
120-27	18748-18755	subject	_
120-28	18756-18761	group	_
120-29	18762-18769	average	_
120-30	18770-18773	and	_
120-31	18774-18784	visualized	_
120-32	18785-18790	using	_
120-33	18791-18794	the	_
120-34	18795-18805	Connectome	_
120-35	18806-18815	Workbench	_
120-36	18816-18823	v.1.2.3	_
120-37	18824-18825	,	_
120-38	18826-18831	while	_
120-39	18832-18843	subcortical	_
120-40	18844-18847	and	_
120-41	18848-18858	cerebellar	_
120-42	18859-18869	activation	_
120-43	18870-18873	was	_
120-44	18874-18882	depicted	_
120-45	18883-18888	using	_
120-46	18889-18896	FSLeyes	_
120-47	18897-18898	(	_
120-48	18899-18901	v.	_
120-49	18902-18908	0.21.1	_
120-50	18909-18910	)	_
120-51	18911-18912	,	_
120-52	18913-18915	as	_
120-53	18916-18919	the	_
120-54	18920-18929	Workbench	_
120-55	18930-18934	does	_
120-56	18935-18938	not	_
120-57	18939-18948	represent	_
120-58	18949-18960	subcortical	_
120-59	18961-18971	structures	_
120-60	18972-18974	or	_
120-61	18975-18978	the	_
120-62	18979-18989	cerebellum	_
120-63	18990-18991	.	_

121-1	18992-18998	Tables	_
121-2	18999-19003	were	_
121-3	19004-19013	generated	_
121-4	19014-19018	with	_
121-5	19019-19022	FSL	_
121-6	19023-19025	's	_
121-7	19026-19032	autoaq	_
121-8	19033-19037	tool	_
121-9	19038-19039	,	_
121-10	19040-19045	which	_
121-11	19046-19053	queries	_
121-12	19054-19061	whether	_
121-13	19062-19069	regions	_
121-14	19070-19072	of	_
121-15	19073-19081	clusters	_
121-16	19082-19088	belong	_
121-17	19089-19091	or	_
121-18	19092-19095	not	_
121-19	19096-19098	to	_
121-20	19099-19102	one	_
121-21	19103-19105	of	_
121-22	19106-19113	various	_
121-23	19114-19121	atlases	_
121-24	19122-19131	available	_
121-25	19132-19133	.	_

122-1	19134-19141	Atlases	_
122-2	19142-19146	used	_
122-3	19147-19155	included	_
122-4	19156-19159	the	_
122-5	19160-19161	“	_
122-6	19162-19172	Cerebellar	_
122-7	19173-19178	Atlas	_
122-8	19179-19181	in	_
122-9	19182-19188	MNI152	_
122-10	19189-19194	space	_
122-11	19195-19200	after	_
122-12	19201-19214	normalization	_
122-13	19215-19219	with	_
122-14	19220-19225	FNIRT	_
122-15	19226-19227	”	_
122-16	19228-19229	,	_
122-17	19230-19231	“	_
122-18	19232-19246	Harvard-Oxford	_
122-19	19247-19255	Cortical	_
122-20	19256-19266	Structural	_
122-21	19267-19272	Atlas	_
122-22	19273-19274	”	_
122-23	19275-19276	,	_
122-24	19277-19280	and	_
122-25	19281-19282	“	_
122-26	19283-19297	Harvard-Oxford	_
122-27	19298-19309	Subcortical	_
122-28	19310-19320	Structural	_
122-29	19321-19327	Atlas.	_
122-30	19328-19329	”	_
122-31	19330-19333	The	_
122-32	19334-19341	cluster	_
122-33	19342-19346	size	_
122-34	19347-19348	,	_
122-35	19349-19352	max	_
122-36	19353-19364	z-statistic	_
122-37	19365-19366	,	_
122-38	19367-19370	and	_
122-39	19371-19381	coordinate	_
122-40	19382-19384	of	_
122-41	19385-19388	the	_
122-42	19389-19395	center	_
122-43	19396-19398	of	_
122-44	19399-19403	mass	_
122-45	19404-19407	for	_
122-46	19408-19412	each	_
122-47	19413-19420	cluster	_
122-48	19421-19423	is	_
122-49	19424-19432	reported	_
122-50	19433-19434	.	_

123-1	19435-19442	Cluster	_
123-2	19443-19448	names	_
123-3	19449-19453	come	_
123-4	19454-19458	from	_
123-5	19459-19465	autoaq	_
123-6	19466-19473	reports	_
123-7	19474-19475	,	_
123-8	19476-19479	and	_
123-9	19480-19483	for	_
123-10	19484-19489	large	_
123-11	19490-19498	clusters	_
123-12	19499-19500	,	_
123-13	19501-19503	we	_
123-14	19504-19510	report	_
123-15	19511-19514	the	_
123-16	19515-19518	top	_
123-17	19519-19526	regions	_
123-18	19527-19531	from	_
123-19	19532-19538	autoaq	_
123-20	19539-19544	along	_
123-21	19545-19549	with	_
123-22	19550-19553	the	_
123-23	19554-19558	mean	_
123-24	19559-19572	probabilities	_
123-25	19573-19574	(	_
123-26	19575-19580	range	_
123-27	19581-19585	from	_
123-28	19586-19587	0	_
123-29	19588-19590	to	_
123-30	19591-19594	100	_
123-31	19595-19596	)	_
123-32	19597-19598	.	_

124-1	19599-19602	The	_
124-2	19603-19607	mean	_
124-3	19608-19621	probabilities	_
124-4	19622-19625	for	_
124-5	19626-19630	each	_
124-6	19631-19638	cluster	_
124-7	19639-19643	will	_
124-8	19644-19647	not	_
124-9	19648-19651	add	_
124-10	19652-19654	up	_
124-11	19655-19657	to	_
124-12	19658-19661	100	_
124-13	19662-19667	where	_
124-14	19668-19671	the	_
124-15	19672-19679	cluster	_
124-16	19680-19684	lies	_
124-17	19685-19687	on	_
124-18	19688-19691	the	_
124-19	19692-19699	outside	_
124-20	19700-19701	,	_
124-21	19702-19704	or	_
124-22	19705-19707	on	_
124-23	19708-19711	the	_
124-24	19712-19716	edge	_
124-25	19717-19719	of	_
124-26	19720-19721	,	_
124-27	19722-19725	the	_
124-28	19726-19730	ROIs	_
124-29	19731-19739	featured	_
124-30	19740-19742	in	_
124-31	19743-19746	the	_
124-32	19747-19752	atlas	_
124-33	19753-19754	.	_

125-1	19755-19760	Large	_
125-2	19761-19774	probabilities	_
125-3	19775-19779	were	_
125-4	19780-19790	associated	_
125-5	19791-19795	with	_
125-6	19796-19800	Left	_
125-7	19801-19803	or	_
125-8	19804-19809	Right	_
125-9	19810-19818	Cerebral	_
125-10	19819-19825	Cortex	_
125-11	19826-19829	and	_
125-12	19830-19834	Left	_
125-13	19835-19837	or	_
125-14	19838-19843	Right	_
125-15	19844-19849	White	_
125-16	19850-19856	Matter	_
125-17	19857-19858	,	_
125-18	19859-19862	but	_
125-19	19863-19868	these	_
125-20	19869-19873	were	_
125-21	19874-19881	omitted	_
125-22	19882-19886	from	_
125-23	19887-19890	the	_
125-24	19891-19897	tables	_
125-25	19898-19900	as	_
125-26	19901-19905	they	_
125-27	19906-19910	were	_
125-28	19911-19926	non-informative	_
125-29	19927-19928	.	_

